{"title": "Efeito da estimulação magnética transcraniana na sensação e no impacto gerados pelo zumbido em pacientes portadores de zumbido crônico subjetivo", "authors": ["Pinto, Patrícia Ciminelli Linhares", "Nardi, Antonio Egidio orient.", "Universidade Federal do Rio de Janeiro. Instituto de Psiquiatria."], "abstract": "ntrodução: Aproximadamente 1-2% da população apresenta zumbido severo, com impacto importante na qualidade de vida. A ocorrência de transtornos psiquiátricos é bastante alta em pacientes com zumbido e se correlaciona diretamente com o grau de incômodo com o sintoma. Estudos de neuroimagem funcional revelam alterações neurais, tanto nas vias auditivas quanto em áreas não auditivas do cérebro, principalmente naquelas do sistema límbico, presentes nos pacientes portadores de zumbido crônico. Não há dúvida, portanto, de que o zumbido é gerado no cérebro e de que tratamentos voltados para modulação dessa atividade neural não funcional podem ser a chave para a melhora dos pacientes. Apesar da vasta literatura sobre tratamento do zumbido, ainda não há um tratamento compravadamente eficaz para a cura do sintoma ou redução de sua intensidade. Estudos placebo controlados revelam benefício com o uso da estimulação magnética transcraniana repetitiva (EMTr) no tratamento do zumbido, porém, a melhora é moderada e temporária, indicando a necessidade de novos protocolos de estimulação. O envolvimento do córtex pré frontal dorsomedial (CPFDM) na fisiopatologia do zumbido torna esta área um alvo potencial no tratamento destes pacientes.", "bibliography_pages": [79, 84], "keywords": ["Zumbido", "Estimulação magnética transcraniana", "Córtex pré-frontal"], "urls": ["http://objdig.ufrj.br/52/teses/920894.pdf"], "pdf_url": "http://objdig.ufrj.br/52/teses/920894.pdf", "id": "920894", "sentences": ["Resumo da tese de doutorado submetida ao programa de pós graduação em psiquiatria e saúde mental (Propsam) do Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro como parte dos requisitos necessários para a obtenção do título de doutor em psiquiatria e saúde mental", "Resumo Introdução: Aproximadamente 1-2% da população apresenta zumbido severo, com impacto importante na qualidade de vida. A ocorrência de transtornos psiquiátricos é bastante alta em pacientes com zumbido e se correlaciona diretamente com o grau de incômodo com o sintoma. Estudos de neur oimagem funcional revelam alterações neurais, tanto nas vias auditivas quanto em áreas não auditivas do cérebro , principalmente naquelas do sistema límbico, presentes nos pacientes portadores de zumbido crônico . Não há dúvida, portanto, de que o zumbido é gerado no cérebro e de que tratamentos voltados para modulação dessa atividade neural não funcional podem ser a chave para a melhora dos pacientes. Apesar da vasta literatura sobre tratamento do zumbido, ainda não há um tratamento compravadamente eficaz para a cura do sintoma ou redução de sua intensidade. Estudos placebo controlados revelam benefício com o uso da estimulação magnética transcraniana repetitiva (EMTr) no tratamento do zumbido, porém, a melhora é moderada e temporária, i ndicando a necessida de de novos protocolos de estimulação . O envolvimento do córtex pré frontal", "dorsomedial (CPFDM) na f isiopatologia do zumbido torna esta área um alvo potencial no tratamento destes pacientes. Objetivo : o obje tivo deste trabalho é descrever e apresentar o resultado dos efeitos da EMTr no CPFDM bilateral em pacientes com zumbido crônico subjetivo em um ensaio clíncio randomizado, à luz das informações de outros cinco artigos escritos sobre zumbido, sua relação com transtornos psiquiátricos, com estresse e seu tratamento . Método : Estão apresentados a seguir 5 artigos já publicados, e um artigo submetido. Todos os 6 artigos versam sobre a relação do zumbido com os transtornos psiquiátricos e o estresse e sobre o tratamento do zumbido , incluindo o ensaio clínico realizado , cego, randomizado e placebo controlado com EMTr. Neste, v inte e nove voluntários receberam 20 sessões de EMTr bilateral, de 10 Hz sobre o CPFDM a 120% do limiar motor do extensor do hallucis longus , por um total de 30 minutos de estimulação, 5 vezes por semana, consecutivamente, por 4 semanas, utilizando uma bobina resfriada em forma de 8. O impacto da intervenção sobre os 3 desfechos de interesse, Tinnitus Handicap Inventory (THI) , medida da intens idade do zumbido (loudness ) e Escala visual analógica (EVA) , foi avaliado através de modelos de regressão para dados longitudinais (medidas repetidas) utilizando as informações coletadas no baseline e nas 4 visitas subsequentes 1, 2, 4 e 16 semanas após o fim do tratamento. Resultados do ensaio clínico : Após o tratamento, houve redução significativa d o THI no grupo ativo, com redução de 11.52 pontos na escala (95% IC: -23.1 a 0.0; p=0.05) assim como do loudness, com p valor limítrofe (redução de 4.46 dB 95% CI: -9.60 a 0.68 dB, p=0.09) . O cálculo do tamanho do efeito (d -Cohen), utilizando os resultados de 16 semanas,mostraram um tamanho de efeito grande em ambas as medidas", "(0.88 and 1.04, respectivamente ). Os resultados da EVA não foram diferentes entre os g rupos .", "Conclusão: Os trabalhos descritos reforçam a relação do zumbido, e do incômodo relacionado ao sintoma, com transtornos psiquiátricos e estresse , que resulta em significativa redução na qualidad e de vida dos pacientes. O uso da neuromodulação através da EMTr parece ser um tratamento promissor para o zumbido. O tratamento do zumbido utilizando EMTr ativa de alta frequência no CPFDM bilateral por 20 sessões mostrou -se eficaz na redução do incômodo gerado pelo zumbido, avaliado pelo THI, e na redução na intensidade do zumbido, medida pelo loudness , quando comparado ao grupo pla cebo. Palavras chave: zumbido, estimulação magnética transcraniana repetitiva, córtex pré frontal dorsomedial , psiquiatria, transtornos psiquiátricos, ansiedade, transtorno do pânico, depressão, estresse .", "Rio de Janeiro Julho 2020", "Transcranial magnetic stimulation for the treatment of chronic subjective tinnitus: impact on tinnitus annoyance and intensity PATRICIA CIMINELLI LINHARES PINTO", "Orientador: Antonio Egidio Nardi Co orientador: Sergio Eduardo de Carvalho Machado", "Abstract da tese de doutorado submetida ao programa de pós graduação em psiquiatria e saúde mental (Propsam) do Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro como parte dos requisitos necessários para a obtenção do título de doutor em psiquiat ria e saúde mental", "Abstract Introduction: Approximately 1 -2% of the population report severe tinnitus, with daily life impairment. The occurrence of psychiatric disorders is high in tinnitus patients and it is directly associated with its annoyance. Neuroimaging studies reveal neural functional abnormalities in central auditory and non -auditory pathways, especially in the limbic system, in tinnitus patients. There is no doubt that tinnitus is generated in the brain and that treatments based on neurom odulation might be the key for tinnitus treatment. D espite the great amount of literature concerning tinnitus treatment, there are still no evidence - based established treatments for curing tinnitus or for effectively reducing its intensity . Sham-controlled studies reveal benefits using rTMS in tinnitus, although improvement is moderate or temporary, indicating need for new strategies. Evidence that dorsomedial p refrontal cortex (DMPFC ) is important in tinnitus pathophysiology make this area a new and promising target. Objective : The objective of the study is to describe our published work about tinnitus, psychiatric disorders, stress and tinnitus treatment , being the most important work a", "randomized clinical trial to evaluate the effect of repetitive transcranial magnetic stimulation (rTMS) targeting the (DMPFC) in the treatment of chronic subjective tinnitus . Method : We describe 5 published articles, and one submitted article. They were based on our study regarding tinnitus, psychiatric disorders , stress and tinnitus treatment, focused on a randomized, blind, sham controlled clinical trial on rTMS for tinnitus treatment. Twenty nine volunteers were submitted to 20 session s of bilateral , 10Hz DMPFC rTMS at 120% of the resting motor threshold of the extensor hallucis longus , for a total stimulation time of 30 minutes, 5 times a week, consecutively, for 4 weeks, using the fluid -cooled figure 8 coil. The impact of the intervention on the three evaluated outcomes, Tinnitus Handicap Inventory (THI) , measure of tinnitus loudness in the audiometric booth ( loudness ) and Visual Analog S cale (VAS), was obtained through a regression model for longitudinal data (repeated measures) using the information from baseline and follow up visits at 1, 2, 4 and 16 wee ks after treatment. Results of the clinical trial: After treatment there was a significant reduction in THI in the active group, a reduction of 11.52 points in the scale (95% IC: -23.1 a 0.0; p=0.05) , as well as in loudness , a borderline p value (reduction of 4.46 dB 95% CI: -9.60 a 0.68 dB, p=0.09) . The effect size ( d-Cohen ) using the 16 week results revealed a strong effect for both measures (0.88 and 1.04, respectively) . VAS results were not significantly different between the groups . Conclusion: The mentioned wo rk and articles strengthen the rela tionship between tinnitus, its annoyance and psychiatric disorders, including stress , resulting in a significant reduction of patient´s quality of life . Tinnitus treatment with high frequency (10Hz), bilateral, dorsomedial prefrontal cortex rTMS was effective in reducing tinnitus annoyance", "measured by the Tinnitus Handicap Inventory and tinnitus loudness when compared to sham stimulation. Key words : tinnit us, repetitive transcranial magnetic stimulation, rTMS, dorsomedial prefrontal cortex , psychiatry, psychiatric disorders, anxiety, panic disorder, depression, stress .", "Rio de Janeiro Julho 2020", "LISTA DE ABREVIATURAS, SÍMBOLOS E SIGLAS: CPFDL – córtex pré frontal dorsolateral CPFVM – córtex pré frontal ventromedial CPFDM – córtex pré frontal dorsomedial CCA - córtex cingulado anterior ReBEC – Registro Brasileiro de Ensaios Clínicos TCC – terapia cognitivo comporatamental EMTr – estimulação magnética transcraniana repetitiva CTP – córtex temporo -parietal TQ – Tinnitus Q uestionnaire MINI - Entrevista Diagnóstica Neuropsiquiátrica Estruturada para o DSM V – Mini International Neuropsychiatric Interview versão 5.0 THI – Tinnitus Hand icap Inventory EVA – escala análogo -visual MML – minimal masking level (nível mínimo de mascaramento) IPUB – Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro UFRJ – Universidade Federal do Rio de Janeiro Hz – Hertz dB – decibéis LM – limiar motor IC – intervalo de confiança", "1) Introdução 1.1) Zumbido: definição e epidemiologia O zumbido subjetivo é caracterizado pela percepção de um som ou ruído nos ouvidos ou na cabeça sem a presença de um estímulo acústico externo. O sintoma afeta aproximadamente 15% da população mundial (Coelho, Sanchez e Bento , 2004). Embora o zumbido possa ocorrer em qualquer período da vida, a maior parte dos pacientes com zumbido tem idade entre 40 e 80 anos e sua prevalência aumenta para 33% nas pessoas com mais de 60 anos de idade (Jastreboff e Hazel l, 1993). Em aproximadamente 1 -2% da população geral (20% dos pacientes com zumbido) esta condição causa um considerável desconforto e interfere de forma severa na qualidade de vida, com incapacidade do indivíduo levar uma vida normal, podendo haver reperc ussão no sono, concentração, impacto emocional e na vida social. Estudo da Public Health Agency of America destacou o zumbido como o terceiro pior problema que pode acometer o ser humano, perdendo somente para dor e tontura crônicas . A alta prevalência do zumbido indica que o sintoma representa um grande problema global (Sanchez et al, 1997) .", "Noventa porcento dos portadores de zumbido apresentam algum grau de perda auditiva ao exame audiométrico. Modelos atuais demonstram que o zumbido ocorre por alterações plásticas cerebrais compensatórias como resultado da diminuição da aferência auditiva para o cérebro; da mesma forma que ocorre na percapção do membro fantasma (Scott et al, 1990; Jastreboff e Hazell, 1993; Moller, 2007; Eggermont , 2007). A relação entre perda auditiva e zumbido é tão grande que pacientes com zumbido e audiometria convencional normal podem ter alteração auditiva em altas frequências , que não são avaliadas ao exame convencional, ou até mesmo apresentarem alterações cocleares mínimas (lesão de até 30% das células ciliadas externas) que não aparecem no exame de audiometria de rotina (Langguth et al, 2007) .", "Apesar da grande necessidade, tentativas de tratar o zumbido de forma eficaz vêm falhando. Metanálise s que avaliam o tratamento do zumbido com estimulação auditiva (próte se auditiva ou terapia sonora), medicações (anticonvulsivantes, antidepressivos, benzodiazepínicos), acupuntura, neuromodulação e terapia cog nitivo -comportamental (TCC), demonstraram eficácia variável na maior parte do estudo s, sem diferença estatística significativa , de cada um desses tratamentos , na redução da intensidade do zumbido quando comparado s ao placebo . A terapia cognitivo -comportamental (TCC)", "parecer ter efeito benéfico na qualidade de vida dos pacientes com zumbid o, reduzindo o incômodo relacionado ao sintoma , mas não apresenta efeitos na sua intensidade . O uso de prótese auditiva, com ou sem gerador de som, ajuda no tratamento da deficiência auditiva e muitas vezes é capaz de reduzir a percepção do zumbido, mas nã o age diretamente na redução da intensidade do sintoma. Medicações , como antidepressivos e ansiolíticos, podem ser usadas para tratamentos de transtornos concomitantes, o que ajuda a melhorar a qualidade de vida do paciente , mas não há evidência suficiente que apoie o seu uso no tratamento do zumbido propriamente dito (Ogawa et al, 2020 ; Bauer, 2018 ; Cima et al, 2019; Tunkel et al, 2014 ).", "1.2) Zumbido: fisiopatologia e neuroimagem O zumbido est á associado a alterações funci onais neurais , tanto nas vias audi tivas quanto em áreas não auditivas do cérebro. Mudanças na atividade e conectividade , associadas ao zumbido , em áreas temporal, frontal, parietal e límbica parecem refletir as alterações patológicas no sistema nervoso central (Schecklmann et al, 2014). As modernas técnicas de neurofisiologia e neuroimagem ajudaram muito na compreensão do funcionamento anormal do sistema nervoso central (auditivo e não auditivo) nos pacientes portadores de zumbido c rônico. Hoje, já não há dúvidas de que o zumbido é gerado n o cérebro, fruto de alteraçõ es plásticas cerebrais não funcionais (Moller, 2007; Eggermont, 2007; Leaver et al, 2012; Seydell -Greenwald et al 2012; Rauschecker et al, As alterações funcionais no sistema nervoso auditivo central de pacientes com zumbido incluem aumento da taxa de disparo neural espontâneo e aumento da sincronia neural. O aumento da taxa de disparo neural espontâneo no núcleo coclear dorsal é observado nas células que persistem após dano coclear, as células fusifo rmes. Este fato desvia o equilíbrio cortical, de excitação/inibição, para uma diminuição da inibição pela deaferentação, que ocorre como resultado da perda de audição, gerando, consequentemente, aumento da excitação dos neurônios auditivos (Lanting et al, 2009; Roberts et al, 2010; Eggermont et al, 2004; Eggermont et al, 2012; Davies et al 2014). Há evidências de alterações nos mapas tonotópicos corticai s (córtex auditivo) após deafere ntação auditiva, resultando em aumento da excitação dos neurônios, sincr onia neural e aumento dos disparos espontâneos de neurônios corticais e subcorticais. Além disso, estudos revelam a presença de disfunção tálamo cortical, hiperexcitabilidade do", "cótex temporo -parietal, do colículo inferior e do tálamo (Noreña et al, 2011; Schaette et al 2011; Engineer et al, 2013) .", "Desde os primeiros estudos de neuroimagem na área, pesquisadores identificaram anormalidades relacionadas ao zumbido também fora do sistema nervoso auditivo central (Lockwood et al., 1998; Mirz et al., 2000; Sch ulman et al., 1995), frequentemente em estruturas relacionadas ao sistema límbico. Existe a hipótese de que estas áreas es tariam ligadas aos componentes a fetivos do zumbido (Vanneste et al, 2010; De Ridder et al, 2011; Langguth et al, 2011). O termo “siste ma límbico” era originalmente definido como o circuito responsável pelas emoções, conectando formações hipocampais, hipotálamo, córtex cingulado e córtex prefrontal adjacente. Atualmente, também é usado para se referir a outras regiões implicadas no proces so das emoções como amigdala e striatum ventral (Catani et al., 2013). Muitas dessas regiões do sistema límbico implicadas no zumbido , também estão envolvidas na experiência e regulação do afeto, emoções e humor (de Gelder et al., 2011; Drevets et al.,1997 ). De forma não surpreendente, muitos modelos de fisiopatologia do zumbido propõem que as reações negativas ou emocionais ao zumbido parecem estar envolvidas na cronicidade do sintoma (De Ridder et al., 2011; Jastreboff, 1990). Sem dúvida, o zumbido está a ssociado a estresse e humor negativo (De Ridder et al., 2011; Dobie, 2003; Jastreboff, 1990; Schecklmann et al., 2011 ) e aumento da ocorrência de depressão e an siedade (Folmer et al., 1999). Desde 1990, Pawel Jastreboff já idealizara o modelo neurofisiológ ico do zumbido que demonstrava que os pacientes que se incomodavam com o zumbido apresentavam uma ativação anormal do sistema límbico e, ainda, aqueles que tinham zumbido incapacitante apresentavam também ativação anormal do sistema nervoso autônomo. Os estudos posteriores só vieram a confirmar estes achados do envolvimento das áreas auditivas e límbicas e suas conexões não funcionais (Schlee et al, 2008, 2009; Lanting et al, 2009; De Ridder et al, 2011) nos pacientes com zumbido. Nestes estudos , o córtex p ré frontal dorsolateral (CPFDL) direito foi identificado como área importante (Schlee et al 2008, 2009; Vanneste et al, 2010). Da mesma forma, foi encontrado que o córtex prefrontal ventromedial (CPFVM) está consistentemente relacionado ao zumbido (Leaver et al., 2012, 2011; Mühlau et al., 2006; Seydell -Greenwald et al., 2014, 2012 ; Leaver et al, 2016 ), assim como a região estriatal ventral (Leaver et al., 2011), o tálamo posterior (Mühlau et al., 2006) e regiões dorsais prefrontais – córtex prefrontal dors omedial (CPFDM) ( Rauschecker et al, 2016; Leaver et al., 2012; Seydell -Greenwald et al., 2012).", "O có rtex cingulado anterior (CCA) parece ter um papel específico no zumbido, sendo responsável pela integração do processamento emocional e cognitivo do zumbid o. Existe a hipótese de que o CCA esteja criticamente envolvido no controle da atenção do processamento auditivo e na geração do zumbido (Vanneste et al, 2011). Leaver et al ., 2012 confirmaram que pacientes com zumbido crônico apresentam redução da substân cia cinzenta no CPFVM comparado ao controle pareado por idade e perda auditiva. Esta alteração não estava relacionada ao incômodo com o zumbido, ansiedade ou depressão, sensibilidade a sons ou outros fatores. Sintomas de ansiedade e depressão estavam relac ionados negativamente à espessura cortical no CCA. Os pacientes portadores de zumbido apresentaram redução da substância cinzenta e aumento da girificação do CPFDM, que se apresentava de forma mais intensa nos pacientes com percepção constante do zumbido. Outras regiões não auditivas também vêm sendo implicadas na geração do zumbido incluindo regiões parahipocampais (Landgrebe et al., 2009; Maudoux et al., 2012; Mirz et al., 2000) e córtex cingulado posterior (Maudoux et al., 2012; Ueyama et al., 2013). O d esafio ao interpretar as alterações centrais não auditivas reside na determinação de estarem relacionadas à geração e cronificação do sinal do zumbido em si ou de estarem associadas às reações e emoções relacionadas ao zumbido. Como um grande percentual de alterações centrais não auditivas estão presentes em estruturas do sistema límbico, avaliação cuidadosa do impacto do zumbido na qualidade de vida e da presença de depressão e ansiedade associadas deve m ser uma importante s considerações .", "1.3) Tratamento d o zumbido Os tratamentos tradicionais como medicação, estimulação sonora e terapia cognitiva comportamental apresentam eficácia limitada no tratamento do zumbido (Tunkel et al, 2014; Bauer et al, 2018; Onishi et al 2018 ; Cima et al, 2019; Ogawa et al, 2020). Os estudos com medicação não se mostraram mais eficazes que placebo, portanto, não há medicamento comprovadamente eficaz para o tratamento do zumbido (Langguth et al, 2013). Muitos estudos com medicação apresentam baixa qualidade, sendo poucos duplo -cego, placebo controlados. Estudos com vasodilatadores, ginkgo biloba, antidepressivos, anticonvulsivantes benzodiazepínicos, agonistas da dopamina e antagonistas do glutamato não mostraram evidências que recomendem o uso dessas medicaçõe s no tratamento do zumbido. A TCC e as terapias sonoras têm importante papel em retirar o foco do zumbido e diminuir a hipervigilância relacionada ao sintoma, porém,", "não eliminam o zumbido e sim ajudam na diminuição da sua percepção. Revisã o da Cochrane Database (Hoare et al , 2014) sobre amplificação com prótese auditiva em pacientes com zumbido e perda de audição revelou evidência limitada na indicação de prótese de amplificação para melhora do zumbido. São necessários mais estudos de qualidade para comprovação dos reais ben efícios.", "Publicado em 2014 por Tunkel et al, guideline da Academia Americana de Otorrinolaringologia recomenda somente orientação e aconselhamento, uso de prótese auditiva quando indicado para a perda de audição e TCC para alívio do sintoma. Novos guide lines confirmam a falta de evidência para indicar um tratamento eficaz para o zumbido, confirmando o efeito das terapia psicológicas, especialmente a TCC, o uso de próteses auditivas e geradores de som e a falta d e efeito das medicaç ões diretamente no zumb ido (Bauer et al 2018; Cima et al, 2019; Ogawa et al, 2020) Diante das evidências, existe uma urgente necessidade de abordagens terapêuticas mais eficientes para o tratamento do zumbido.", "1.4) Estimulação magnética transcraniana A estimulação magnética tr anscraniana repetitiva (EMTr) é um procedimento não-invasivo de neuromodulação baseado na lei de Faraday de indução eletromagnética onde uma atividade elétrica no tecido cerebral pode ser influenciada por um campo magnético, induzindo uma nova corrente elé trica que despolariza os neurônios. O tratamento com EMTr pode ser considerado um tratamento de neuromodulação cerebral devido ao seu foco ser direcionado aos circuitos neurais. A EMTr é realizada através de estimulação cortical, utilizando uma bobina, de pulsos repetidos na área onde se quer atuar, podendo gerar , dependendo d a frequência desses pulsos , atividade inibitória ou excitatória no tecido neural estimulado e em áreas funcionalmente conectadas a ela . Os pulsos repetidos de baixa frequência têm o ob jetivo de inibir a atividade neural subjacente e de áreas funcionalmente conectadas e os de alta frequência geram excitatação em áreas funcionalmente inibidas. A EMTr muda a perspectiva de tratamento por alterar a neuroquímica dentro da sinapse, modulando ou modificando a função do circuito neural cerebral que se ac redita estar desorganizada nos transtornos específicos (Hallett, 2007).", "1.5) Zumbido e estimulação magnética transcraniana Estudos piloto evidenciaram os primeiros efeitos benéficos da EMTr de b aixa frequência guiada por ressonância magnética ( RM) e tomografia por emissão de pósitrons (PET) no córtex temporoparietal (CTP) de pacientes com zumbido crônico (Eichhammer et al 2003). Estes ac hados foram replicados em estudos clínicos controlados usand o EMTr de baixa frequência (1Hz), demonstrando redução na gravidade e incômodo relacionados ao zumbido após 5 -10 dias de EMTr ativa no CTP quando comparada a EMTr placebo (Plewnia et al 2007, Rossi et al 2007, Smith et al 2007). Estudos com neuroimagem demonstraram que a EMTr de baixa frequência em regiões auditivas cerebrais é capaz de induzir modificações profundas na substância cinzenta tanto de áreas corticais auditivas quanto no tálamo e em áreas funcionalmente conectadas (Ma y et al 2007). Estudo de Marcondes et al, 2010 usou rEMT de baix a frequência sobre o CTP esquerdo por 5 dias consecutivos em pacientes com zumbido e audição normal e encontrou redução significativa do zumbido quando comparados ao placebo por um período de até 6 meses de follow up ap ós a estimulação. Outros estudos com EMTr de baixa frequência no CTP também revelaram resultados bastante promissores e com tendência a melhora dos grupos submetidos à estimulação ativa (Kleinjung et al, 2005; Folmer 2006; Langguth et al, 2007; Plewnia et al, 2007; Rossi et al, 2007; Smith et al, 2007; Mennemeier 2013; Folmer 2015). Os resultados desses estudos são bastante otimistas, porém, mostraram benefícios moderados, grande variabilidade de resposta individual, além de diferenças nos protocolos utiliz ados e todos indicam necessidade de otimização e refinamento de estratégias e protocolos com aumento das amostras antes que o procedimento seja usado clinicamente (Kreuzer et al, 2011; Folmer et al, 2015).", "Alguns estudos não encontraram benefícios no zum bido após uso de EMTr no CTP. Picirillo et al, 2011 conduziram estudo com EMTr em CTP esquerdo para tratamento do zumbido e não encontraram diferença significativa entre o grupo ativo e o placebo, com protocolo de 5 sessões semanais por 2 semanas. Posterio rmente, em 2013, o mesmo grupo comparou este estudo com um novo protocolo aumentando o tempo de estimulação para 4 semanas e também não encontrou diferença significativa entre os grupos (Picirillo et al, 2013). Estudo multicêntrico de Lan dgrebe et al, 2017 avaliou 167 pacientes randomizados em grupos ativo e placebo, para receber 10 sessões de 1Hz no CTP esquerdo. O tratamento não se revelou mais eficaz que o placebo na redução do incômodo relacionado ao zumbido. Os resultados negativos do estudo vêm sendo", "discutidos (Folmer 2017) devido à grande heterogeneidade dos pacientes portadores de zumbido. No estudo de Landgrebe 2017 a média de idade foi de 49 anos e foram incluídos pacientes com audição normal ou próxima do normal, diferente de outros ensaios clíni cos com resultados positivos.", "Com a evidência de eficácia moderada do uso da EMTr de baixa frequência no CTP, protocolos diferentes, estimulando outras áreas do cérebro relacionadas ao zumbido, isoladamente ou associado ao CTP, foram estudados.", "Kreuzer et al, 2011, compararam EMTr combinada de baixa frequência no CTP esquerdo e CPFDL direito com a estimulação isolada no CTP esquerdo. A estimulação adicional no CPFDL direito parece promissora porém o tamanho do efeito foi pequeno, provavelmente relaciona do à ausência de um grupo placebo, tendo sido o grupo controle também ativo. Da mesma forma, Formá nek et al 2018, usando protocolo semelhante de CTP bilateral baixa frequência e CPFDL esquerdo alta frequência por 5 dias, não encontraram melhora significati va quando comparada ao placebo. Publicação de De Ridder et al, 2012 avaliando o efeito da estimulação de baixa frequência no CPFDL direito em pacientes revelou que há benefícios na redução do zumbido com 10 sessões de EMTr de 1Hz, 7 de 11 pacientes obtiver am melhora da intensidade do zumbido. Langguth et al 2014 avaliaram 192 pacientes portadores de zumbido que foram alocados de forma randomizada em 3 grupos diferentes para receber 10 sessões de: grupo 1 - estimulação placebo de 1Hz, grupo 2 - estimulação ativa 1 Hz no CTP esquerdo e grupo 3 - estimulação ativa 1 Hz CTP esquerda associada a estimulação 20 Hz no CPFDL esquerdo. Os autores não encontraram difrença entre os grupos na avaliação primária de desfecho apesar de os defechos secundários terem se most rado favoráveis aos grupos ativos, em particular ao grupo de estimulação combinada. Lehner et al 2016 avaliaram 49 pacientes submetidos a 10 sessões de EMTr utilizando protocolo com um grupo de estimulação em três áreas diferentes, sem grupo placebo. Um gr upo foi submetido a EMTr 1Hz CTP bilateral associado a 20Hz CPFDL esquerdo e o outro grupo submetido a estimulação 1Hz CTP esquerdo. Houve redução significativa no incômodo gerado pelo zumbido pelo Tinnitus Questionnaire (TQ) em ambos os grupos, sem superi oridade do grupo estimulado em 3 áreas diferentes.", "A descoberta do envolvimento de áreas mais profundas do sistema límbico (CCA, CPFVM, CPFDM) na fisiopatologia do zumbido motivou a elaboração de diferentes", "protocolo s de EMTr com foco nessas áreas . Vanne ste et al, 2011 avaliaram o uso de bobina em duplo cone para estimulação mais profunda no córtex frontal dorsal usando frequências diferentes de estimulação e observaram que estimulação bifrontal de baixa frequência foi eficaz na redução da intensidade e i ncômodo relacionados ao zumbido. Kreuzer et al 2015 compararam estimulação m édio frontal com bobina em duplo cone associado a estimulação de 1Hz no CTP esquerdo com bobina em 8 com grupo de estimulação em CPFDL esquerdo 10Hz associado a CTP esquerdo 1Hz p or 10 sessões. Houve mudança significativa no TQ nos dois grupos, porém, não houve diferença entre os grupos.", "Guidelines no uso terapêutico da EMTr publicado em 2014 por Lefaucheur et al mostra nível de evidência C (eficácia possível) no uso de EMTr para tratamento do zumbido.", "Revisão sistemática de Peng e t al, 2012 sobre a eficácia da EMT r no tratamento do zumbido, incluindo cinco ensaios clínicos, randomizados e controlados, dos quais quatro estimularam o CTP esquerdo por, no máximo, 2 semanas, revelou que houve uma melhora significativa estatisticamente entre o grupo de pacientes com zumbido tratados com estimulação ativa em relação aos tratados com estimulação placebo. Porém, ainda são necessários estudos com follow -up maior assim como avaliação mais eficaz dos parâmetro e número de dias de estimulação, na opinião do autor. Existe ainda necessidade de tentativas para otimizar os protocolos de tratamento.", "Londero et al, 2017 publicaram revisão da literatura incluindo 25 artigos em uso de EMTr no tratam ento do zumbido. Os estudos diferiram muito em metodologia. Local e protocolos de estimulação também variaram de forma importante, sendo a maior parte dos locais de estimulação os CTP esquerdo e CPFDL por 2 semanas ou menos, em sua maioria. Muitos problema s práticos e metodológicos ainda precisam ser resolvidos antes que a EMTr possa ser implementada na prática rotineira para tratamento do zumbido. Muitas são as variáveis envolvidas na avaliação de ensaios clínicos com uso de EMTr no tratamento de paciente s portadores de zumbido, como bem descrito por Folmer  Tamanho da amostra  Idade dos partic ipantes", " Presença ou ausência de perda auditiva  Tempo de zumbido na população avaliada  Poucos estudos randomizados  Poucos estudos com grupo sham  Lateralidade na aplicação da estimulação  Tipo de equipamento de EMTr utilizado e profundidade de penetração do campo magnético com a bobina utilizada  Intensidade da EMTr e determinação do limiar motor  Orientação e posicionamento da bobina  Medidas de desfecho (escalas, med idas do zumbido na cabine audiométrica)  Curto tempo de seguimento pós tratamento Na tabela abaixo encontra -se resumo dos artigos sobre EMTr e zumbido descritos no texto.", "Author Year N rTMS protocol Follow up Results Kleinjung 2005 14Área de maior ativação no PET scan (12 pac no CTP esq e 2 CTP D), 1Hz, 5 dias, 110%LM Baseline, no dia antes, 3 e 6 dias depois e 6 meses depois Redução do TQ no grupo ativo, sustentada por 6 meses. Folmer 2006 15CTP D e E, 10Hz, 30 pulsos a cada min por 5 min, 100%LM Baseline e 20,30,45,60 min depois da EMT 1 e 4 dias após potencial tratamento Langguth 2007 10CTP (região de maior ativação ao PET), 1 Hz, 5 dias, 110%LM Baseline, 1, 5 ,8 e 11 dias após EMT Dependente da excitabilidade talamo-cortical para individualizar tratamento. Plewnia 2007 6CTP na região de máx excitabilidade ao PET, 1Hz, 10 dias cada estimulação, 120%LM Baseline e 2 semanas após EMT Redução na gravidade e incômodo Rossi 2007 16CTP E, 1Hz, 5 dias, 120%LM Baseline, 1 e 2 semanas após EMT Redução significativa mas transitória do incômodo e percepção do zumbido Smith 2007 4CTP E, 1Hz, 5 dias, 110%LM Baseline, imediatamente após e 4 semanas após EMT Redução do incômodo mas não sustentado após 4 semanas Marcondes 2010 19CTP E, 1Hz, 5 dias, 110%LM Baseline, 7, 14, 21 dias e 1, 2, 3, 4, 5 e 6 meses após EMT Melhora significativa do zumbido no grupo ativo kreuzer 2011 56CTP E 1Hz ou CTP E 1Hz + CPFDL D 1Hz, 10 dias, 110%LM Baseline, logo após EMT, 4 e 12 semanas após EMT Melhora do TQ com discreta tendência melhor grupo combinado De Ridder 2013 44CPFDL D 1Hz, 10 Hz e sham Antes e logo depois da EMT Redução significativa do zumbido no grupo ativo 1Hz comparado ao sham. langguth 2014 192CTP E 1Hz; 1 ou 20Hz Cx Frontal E +1Hz CTP E, 10 sessões, 110% LM Baseline, logo após e nos dias 18,25,59,90 após EMT Ativo não superior ao placebo, outcomes secundários favoráveis ao grupo ativo Folmer 2015 64CTP E, 1Hz, 10 dias, 110% LM Baseline, 1,2,4,13 e 26 semanas após EMT Ativo superior a placebo e resposta sustentada Lehner 2016 49CPFDL E , 20Hz + CTP E e D, 1Hz ou CTP 1Hz, ambos os grupos 10 sessões Primeiro e 12, 90 e 180 dias após EMT Bom resultado mas estímulo triplo não superior a única área estimulada Tae-soo noh 2019 30CTP E 1Hz + CPFDL E 1Hz, 4 dias 110% LM 1, 2, 4 e 8 semanas após EMT Efeito benéfico no zumbido quando comparado ao placebo. Piccirillo 2011 14CTP E 1 Hz, 2 semanas, 110%LM baseline, logo após EMT e 4 sem depois EMT Tratamento sem efeito quando comparado ao placebo Piccirillo 2013 14CTP E 1 Hz, 4 semanas, 110%LM Baseline, logo após EMT e 4 sem depois Estimulação ativa não foi superior à estimulação placebo Landgrebe 2017 163CTP E, 1Hz, 10 sessões, 110% LM Baseline, 2 e 26 semanas pós EMT Tratamento ativo não foi superior ao placebo Formanek 2018 53CTP bilateral, 1Hz, 110% LM + CPFDL E 25Hz, 80% LM por 5 dias ou placebo ou medicação (Ginkgo Biloba) Baseline, 1 e 6 meses pós EMT EMT ativa não foi superior ao placebo kan 2019 22CTP E, 1Hz, 10 sessões, 90% LM Baseline e logo após EMT Não houve diferença significativa no zumbido após EMT vanneste 2011 78Cx frontal medial 1,3,5,10,20 Hz 200 pulsos cada até obs da supressão do Z Imediatamente após cada estimulação Estimulação bifrontal medial pode modular intensidade e incômodo zumbido kreuzer 2015 40Cx cingulado anterior 10Hz + CTP E 1Hz ou CTP E 1Hz + CPFDL E 10Hz 10 sessões Baseline, 2, 4 e 12 semanas após EMT Estimulação profunda não foi superior à estimulação superficial Menemeier 2011 21Cx temporal área de maior atividade no PET, 1Hz, 5 sessões, 110% LM baseline, antes e depois de cada dia de EMT Redução do zumbido qdo comparado ao placebo Plewnia 2012 48Theta burst 20 sessões, cx temporal bilat ou CTP bilat ou sham Baseline, 2, 4 semanas pós e 3 meses pós EMT Estimulação não foi superior ao placebo", "2) Justificativa e objetivos:", "De acordo com o exposto acima, a maior parte dos es tudos realizados utilizaram protocolos de estimulação cortical superficial (CTP e CPFDL) com 10 sessões. Poucos são os estudos que utilizaram estimulação cortical profunda por período de 4 semanas. Estudos com uso de EMTr para tratamento de depressão, níve l A de evidência (eficácia definitiva), mostram que o benefício terapêutico é maior com maior números de sessões. O número de respondedores aumenta significativamente quando o número de sessões é maior que 10, quando o número de pulsos por sessão é maior q ue 1000 e quando a intensidade da estimulação é maior que 100% do limiar motor de repouso (Berlim et al, Diante da necessidade de novos tratamentos e otimização de protocolos em EMTr no tratamento do zumbido, baseado nos protocolos bem sucedidos no tratamento da depressão e diante da evidência do envolvimento dos córtices frontais mediais na fisiopatologia do zumbido, o objetivo do nosso estudo foi avaliar o uso de 20 sessões de EMTr aplicada no córtex pré -frontal dorsomedial bilateral para tratame nto de pacientes com zumbido crônico subjetivo.", "3) Métodos O estudo foi aprovado pelo comitê de ética em pesquisa do Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro sob o número CAEE 48853015.6.0000.5263. Trata -se de ensaio clínico ran domizado placebo controlado para avaliação dos efeitos da estimulação magnética transcraniana no córtex pré frontal dorsomedial bilateral no tratamento do zumbido crônico subjetivo. O estudo está registardo e aprovado no Registro Brasileiro de Ensaios Clín icos (ReBEC) sob o número RBR -748nrs.", "3.1) Amostra e avaliação pré estimulação A amostra é composta de 29 pacientes com idade entre 47 e 78 anos, portadores de zumbido uni ou bilateral, sem perda de audição ou com perda auditiva neurossensorial compatível com a idade, há no mínimo 3 meses e no máximo 5 anos, sem transtornos psiquiátricos, excluídos pelo uso do questionário Mini International Neuropsychiatric Interview (MINI) versão 5.0, refratários a outros tratamentos para zumbido como", "medicamentos, terap ias ou uso de próteses auditivas. Os pacientes assinaram o termo de consentimento livre e esclarecido e foram divididos igualmente em dois grupos , de forma randomizada com uso do Excel®: Grupo 1: submetido a estimulação placebo (sham), com uso de bobina pl acebo em forma de 8 posicionada no CPFDM bilateral – 14 pacientes; grupo 2: submetido a estimulação ativa (intervenção) com uso de bobina em 8 ativa poscionada no CPFDM bilateral. Os pacientes envolvidos no estudo foram encaminhados para o projeto já com d iagnóstico de zumbido, devidamente investigados e tratados por pelo menos 3 meses com tratamentos variados, sem sucesso. Eles foram reavaliados no ambulatório do Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro (IPUB/UFRJ). No IPUB foi ap licado o MINI, o Tinnitus Handicap Inventory (THI) e a Escala Visual Analógica (EVA), com o objetivo de rastrear todos os diagnósticos e sintomas psiquiátricos nestes pacientes e avaliar o impacto do zumbido na vida do paciente. Os questionários foram apli cados antes e após o tratamento como método de avaliação de resposta à EMTr. Todos os pacientes foram submetidos a audiometria tonal e vocal e imitanciometria e a medidas do zumbido na cabine audiométrica ( loudness matching, pitch matching e pesquisa do ní vel mínimo de mascaramento -MML). Os exames são indolores e não invasivos e fazem parte da rotina normal da avaliação de pacientes com zumbido, sendo as medidas do zumbido uma forma de mensurar, ainda que subjetivamente, o sintoma do paciente. Os questionár ios e exames foram realizados antes (baseline), 1 semana, 2 semanas 4 semanas e 16 semanas após o tratamento. Os critérios de inclusão foram : indivíduos de ambos os gêneros, com idade e ntre 2 0 e 80 anos, ter diagnóstico de zumbido há pelo menos 3 meses, se m transtorno do humor ou transtorno de ansiedade associados, ter zumbido com incômodo no mínimo moderado ao THI ( mínimo de 38 pontos ). Os critérios de exclusão foram : co-morbidades psiquiátricas, transtorno de personalidade, doenças neurológicas, retardo m ental, epilepsia, abuso de álcool e outras drogas, alterações metabólicas ao exame de sangue que pudessem estar relacionadas ao zumbido, zumbido somatossensorial (relacionado a problemas musculares na região da cabeça e pescoço), doenças da orelha média ou outras doenças do ouvido com tratamentos específicos como doença de Ménière, ototoxicidade, perda auditiva por ruído, surdez súbita, zumbido pulsátil ou zumbido tipo clique. Foi realizada uma avaliação clínica e triagem específica para verificar se os pacientes eram elegíveis para participar do projeto e liberados a receber EMT (Rossi et al., 2009, 2011), juntamente com um exame complementar de EEG de repouso para", "verificação de possíveis focos epiléticos. Portanto, para que um indivíduo fosse submetido à EMTr, este n ão poderia possuir focos epiléticos ou ter passado por episódios de convulsão ou de síncope, não possuir implantes metálicos e cocleares, não possuir estimuladores implantados, não estar grávida e não possuir marca -passo. 3.2) Procedimento expe rimental Os pacientes dos 2 grupos – sham e ativo - foram randomicamente, utilizan do a função de randomização do Excel®, divididos em: grupo 1 foi submetido a EMTr sham com bobina em 8 sham (a energia eletromagnética se afasta do crânio) colocada sobre o córtex pré frontal dorsomedial bilateralmente, local do eletrodo Fz no sistema internacional 10/20 de EEG, posicionado a 25% da distância nasion -ínion. Grupo 2 recebeu EMTr -ativa, com bobina em 8 ativa no córtex pré frontal dorsomedial bilateralmente, calcu lada a posição da mesma forma que o grupo sham. O protocolo consistiu em estimulação de 10Hz sobre o CPFDM bilateralmente a 120% do limiar motor do hallucis longus. Cada sessão de 10Hz de estimulação aplicou 3000 pulsos em cada hemisfério, não simultaneame nte (6000 pulsos no total), com ciclos de 5 segundos de pulsos e 10 segundos de pausa, por um total de tempoo de estimulação de 30 minutos (15 minutos em cada lado), 5 vezes por semana, consecutivamente por 4 semanas (Hadley et al, 2011; Mir -Moghtadaei, 20 16; Downar, 2014), usando uma bobina em 8 refrigerada com equipamento Neuro -MS/D.", "3.3) Instrumentos de avaliação Foram utilizados nos momentos pré e pós -tratamento, os seguintes instrumentos de avaliação dos sintomas:", "1) Tinnitus Handicap Inventory (THI): Trata-se de questionário com 25 perguntas para avaliação do impacto do zumbido nos aspectos funcional, emocional e catastrófico na vida do paciente. É um questionário de auto resposta, o nde o paciente deve reposnder se sim, não ou às vezes para cada uma das perguntas. A resposta sim pontua 4 pontos, a às vezes 2 pontos e não zero pontos. O resultado varia de 0 a 100 e o resultado pode ser: 0-16 discreto; 18 -36 leve; 38 -56 moderado; 58 -76 severo; 78 -100 catastrófico. - Anexo 1 (Newman et al, 1996; Ferreira et al, 2005).", "2) Mini International Neuropsychiatric Interview (MINI v5.0): Questionário para diagnóstico de transtornos psiquiátricos.", "3) Escala Visual Analógica (EVA): Escala em que o paciente deve dar uma nota de 0 a 10 para as seguintes pergutas: de 0 a 10 qua nto o seu zumbido te incomoda? De 0 a 3.4) Exame de audiometria e medidas do zumbido Audiometria:", "O exame é realizado com o paciente dentro de uma cabina acusticamente tratada, e ambos os equipamentos dev em ser calibrados frequentemente.", "A audiometria tonal para avaliação da condução aérea é realizada a partir da apresentação de um tom puro às orelhas através de fones de ouvido sendo medida a menor intensidade em decibéis na qual esse som é percebido em 5 0% das vezes. O teste é repetido de 250 a 8000Hz de cada lado e os dados registrados no audiograma. Depois, a avaliação da condução óssea é feita através de um vibrador no processo da mastóide, sendo medido o limiar nas mesmas frequências (Momensohn -Santo, 2011). Medidas do zumbido:", "Ainda dentro da cabina e com fones de ouvido primeiramente o paciente deve identificar se seu zumbido se parece com um tom puro ou com um ruído tipo banda estreita. Após a identificação, os sons são apresentados - na orelha co ntralateral ao zumbido nos casos de zumbido unilateral, contralateral ao pior zumbido nos zumbidos bilaterais assimétricos, na orelha de melhor audição nos zumbidos simétricos e na orelha direita nos casos de audição e zumbido simétricos - em diferentes fr equências entre 500 e 12000 Hz e o paciente deve avisar qual a frequência mais parecida com o zumbido. Em seguida o paciente identifica o volume de som necessário, na frequência do zumbido, que se iguala ao volume do zumbido, aumentando -se o som transmitid o pelo fone de 1 em 1 dB, acima do limiar naquela frequência identificado pela audiometria (Henry, 2016; Henry et al, 2000).", "3.5) Aplicação da estimulação magnética transcraniana repetitiva (EMTr) Foi utilizada uma bobina em formato 8 angulada e refri gerada (70 mm). Os pacientes se sentaram em uma cadeira confortável do tipo dentista e foi utilizada uma touca para demarcação do local a ser estimulado e protetores auriculares. O limiar motor (LM) de cada paciente foi verificado através do método de Ros sini e Rossi (2007). Para verificar a intensidade da estimulação, estímulos simples supra - liminares foram aplicados sobre o córtex motor primário para determinar a área de estimulação do músculo abdutor breve do polegar (região onde a resposta de potencial motor evocado é mais intensa ao estímulo), referente ao ponto de colocação do eletrodo C3 do sistema internacional de 10 -20 de EEG (Jasper, 1958). A carga da máquina foi diminuída em 2% até que fossem observados movimentos do polegar em um mínimo de 5 de 10 tentativas, sendo a intensidade correspondente ao limiar motor do paciente. Posteriormente a bobina foi posicionada na linha média para se obter o limiar motor do hallucis longus , utilizando a mesma técnica do abdutor do polegar. As aplicações foram re alizadas sobre o CPFDM direito e esquerdo conforme descr ito anteriormente. A bobina foi colocada sobre a superfície do crânio (escalpo) através de um braço mecânico (Neurosoft -Equipamentos Médicos, Brasil). Pa ra o grupo de EMTr placebo, foi utilizada uma b obina que simula a estimulação ativa, promovendo sensações cutâneas e ruídos idênticos ao da bobina real.", "3.6) Análise estatística A distribuição das variáveis socio -demográfica e clínicas foram calculadas em ambos os grupos (ativo e placebo) para descri ção da amostra e para avaliar o equilíbrio alcançado com a randomização.", "O impacto da intervenção nos defechos selecionados (THI, tinnitus loudness matching e EVA) foi avaliado através de modelos de regre ssão para dados longitudinais (medidas repetidas) u tilizando e stimativa de probabilidade máxima re strita de efeitos mistos (REML). Esses modelos consideram a correlação entre as medidas coletadas do baseline até o final do tratamento (1, 2, 4 e 16 semanas) no mesmo indivíduo. Três modelos foram utilizados , um para cada desfecho (variáveis dependent es). A variável independente foi a intervenção (codificada 1: EMTr ativa ; 0:", "estimulação placebo ). Graficos bidimensionais foram criados com a s trajetória s individuais e as curvas suavizadas utilizando lowess (locally weighted scatterplot smoothing ) com 95% de interva ol de confiança para mostrar as tendências nos grupos ativo e placeb o durante o período de seguimento .", "O tamanho do efeito foi calculado pela estatística do d de Cohen , e representa a diferença padr onizada entre os grupos durante o período de seguimento. Uma interpretação comumente utilizada é a que se refere ao tamanho do efeito como pequeno Os resultados foram considerados estatisticamente significativos pa ra p valor ≤ 0.05, e com significância limítrofe quando o p valor foi entre 0.06 -0.10 2. Todas as análises foram relizadas utilizando Stata 14.0.", "Os resultados finais da pesquisa, discussão e conclusão serão descritos abaixo na forma de artigo, aprovado para publicação na revista Ear and Hearing .", "4) Estudos publicados e submetidos para publicação 4.1) Estudo 1 – publicado na Journal of Laryngology and Otology. Premiado melhor artigo de revisão da revista de 2014.", "Tinnitus and its association with psychiatric disorders: systematic review Jul 17.", "Pinto PC , Marcelos CM , Mezzasalma MA , Osterne FJ , de Melo Tavares de Lima MA, Nardi AE .", "Introduction Tinnitus is a symp tom defined as a sound in the ears or head without the production of any sound by an external source. The symptom affects approximately 15% of the world population1. Although tinnitus may occur at any time in life, most patients are between 40 and 80 year s of age and tinnitus' prevalence rises to 33% in patients older than 602.", "Tinnitus has been associated with a great variety of psychological and psychiatric disorders3-6. Studies show that 48 -60% of the patients with chronic tinnitus who are annoyed by t he symptom have an associated diagnosis of major depression7-8. Simpson et al. observed psychiatric diseases in 46% of patients with tinnitus9. Zoger et al. found anxiety disorders in 45% of their tinnitus patients10. Many other studies show a strong corre lation between tinnitus severity and psychological and psychiatric factors such as mood disorders, reduction in concentration, irritability and loss of control10-17. Most studies indicate a relationship between tinnitus annoyance and the presence of certai n psychiatric diagnoses and specific personality traits4;11;18 -20. Unterrainer et al (2003)4 described depression and tinnitus intensity as the best predictors of the perception of tinnitus´ intensity severity and of consequent annoyance.", "Langguth et. al (2007)20 confirmed the role of anxiety and depression as predictors of tinnitus severity using the Tinnitus Handicap Inventory (THI). The relationship", "between personality traits, depressive mood and tinnitus severity is highly relevant to the diagnosis and prognosis of the degree of the handicap related to tinnitus20-21. Depression frequently occurs with tinnitus8 and usually increases the functional handicap of tinnitus´ patients22.", "It is very important to identify and adequately treat the mental dis orders that can be associated with tinnitus because theses disorders might greatly affect a patient's quality of life. The objective of the present study is to systematically review the literature on the occurrence of psychiatric diagnoses in the tinnitus -affected population and to correlate the presence of a psychiatric disorder with annoyance and severity related to tinnitus. Methods To compile the article selection for this review, electronic searches were performed in the PubMed, ISI -Web of Science an d SciELO databases. All years were initially included, resulting in 806 articles. The period of time was limited to January 2000 to December 2012 to include most recent studies that include the most common psychiatric diagnosis criteria and tinnitus annoya nce measurements. The terms used as keywords were “tinnitus”, psychiatric”, “mental disorders” and “psychological”. The terms were matched to generate a more specific search. The combination of the keywords is demonstrated in figure 1.", "The main requiremen t for an article to be included in this review was the presentation of original research on psychiatric disorders and tinnitus, mostly with a focus on mental disorders, such as anxiety and/or mood disorders. The individuals participating in the selected re search had to be more than 18 years old and tinnitus had to be present for at least 3 months. Psychosis cases and patients with personality and somatoform disorders were excluded. Other exclusion criteria were: patients who presented with tinnitus related to acute and chronic otitis media, outer ear diseases, or conductive or mixed hearing losses, patients who had undergone ear surgery, patients with Meniere's disease, somatosensory tinnitus or tinnitus related to metabolic diseases and studies that evalua ted only psychological aspects instead of psychiatric diagnosis or symptoms. All languages were searched, but only papers in English and Portuguese were included in the final selection. Only original articles were included, so review articles, book chapter s, dissertations and letters to the editor were excluded.", "After all database selection, manual searches of the reference list of the reviewed articles were performed. Ultimately, 16 papers were chosen to be included in this review. Figure 2 shows the selection process, and table 1 presents the final article list. Results For psychiatric evaluation, many studies used more than one scale to define the symptoms and diagnosis (nine studies). Most of the studies used the Structured Clinical Interview (SCID) an d its different versions for the Diagnostic and Statistical Manual for Mental Disorders (DSM III or DSM IV) (five studies); the Mini International Neuropsychiatric Interview (MINI) (two studies); the Hospital Anxiety and Depression Scale (HADS) (five studi es) or the Beck Depression Inventory (BDI) and its different versions (five studies). Only one article used the Beck Anxiety Inventory (BAI). Other instruments used in different studies were: the Hopkins Symptoms Checklist, the Comprehensive Psychopatholog ical Rating Scale (CPRS), the Toronto Alexithymia Scale (TAS -20), the State Anxiety Inventory Trait and/or the State (STAI -t or STAI -s), the Symptom Checklist -90 Revised (SCL -90-R), the Anxiety Sensitivity Index (ASI), the Composite International Diagnosti c Interview Short Form (CIDI -SF), the Maudsley Obsessional -Compulsive Inventory (MOCI) or a self -rating depression scale (SDS)6,10- When evaluating tinnitus severity and tinnitus' impact on the quality of life, six studies used the THI, two used the Tinnitus Severity Questionnaire (TSQ), and two used the Tinnitus Reaction Questionnaire (TRQ). The other scales used were: the Nottingham Health Profile (NHP) and the Tinnitus Severity Index (TSI). Several studies only evaluated the prevalence of psych iatric disorders in patients with tinnitus or no tinnitus and other studies used a specific self -completion questionnaire or a semi -structured interview.", "Fifteen of the 16 reviewed studies were consistent with a high prevalence of psychiatric diagnosis in patients with tinnitus, and nine studies evaluated and showed a significant correlation between the presence and severity of these psychiatric disorders and the severity and annoyance by tinnitus, that is, the presence of comorbid psychiatric disorders w orsened the prognosis of tinnitus disability.", "Bartels et al, (2008)23 evaluated 265 tinnitus patients and found that 41% had no psychiatric symptoms using the HADS. Of the patients with psychiatric symptoms, 10.2% had only anxiety, 9.8% had only depress ion and 39.2% had depression plus anxiety. The researchers concluded that concurrent anxiety and depression have an additive effect reducing the general and tinnitus specific health -related quality of life and increasing maladaptive coping abilities.", "Mala kouti et al, (2011)6 found a high prevalence of at least one axis I lifetime psychiatric diagnosis in tinnitus patients (56% in male patients and 69% prevalence in female patients) and the difference was significant (p=0,01). The most prevalent disorders were anxiety and major depression. The frequency of major depression, anxiety and somatoform disorders was significantly higher in females than in males (p<0.01). In total, 75% of women received a severe score on the THI compared with 63.9% of men. The study showed that regarding psychiatric diagnosis or symptoms, there was no significant association between the THI and the presence of mental disorders.", "A study by Salonen et al, (2007)14 was the only one to study the presence of alexithymia in tinnitus pati ents. The researchers observed that the subjects who had tinnitus and were not annoyed by tinnitus were most commonly alexithymic (OR=2.2, 95%, CI=1.3 -3.6) with a high TAS score. The patients who were annoyed by their tinnitus were also commonly alexithymi c compared with the patients without tinnitus (OR=1.7, 95%, CI=1.0 -2.9), and had a high TAS score, but the score was lower than for the non - annoyed group. Depression was associated with harmful tinnitus among women in a pairwise analysis, but the associati on disappeared in a multivariate analysis. In conclusion there was an association between alexithymia and tinnitus, but a detailed analysis showed that alexithymia was not helpful in explaining tinnitus annoyance.", "A study performed by Ooms et al in 201124, evaluating 136 patients using the BDI and THI, found depressive sym ptoms in the patients tha t were: 16.9% mild, 10.3% moderate, and 5.9% severe. Of the patients with a severe tinnitus handicap, 17.2% also reported severe depressive symptoms and no patien ts with catastrophic tinnitus reported severe depressive symptoms. The THI and BDI scores were significatly correlated. To check whether the correlation could be explained by content overlap, a linear regression was performed, with THI scores as the depen dent variable and scores on the three subscales of the BDI -II as the independent variables. Only the somatic depression", "subscale significantly predicted subjective tinnitus severity. The authors suggested that the relationship between depression and tinnit us is far less obvious than is currently assumed. It is important to distinguish between somatic symptoms that are a consequence of tinnitus and somatic symptoms that are indicators of depression. One study by Folmer et al, (2008)16, specifically evaluate d the influence of obsessive -compulsive disorder (OCD) in tinnitus patients and found that a high MOCI score correlates with high values for tinnitus loudness and high scores on the TSI. A study by Andersson et al found a very high prevalence of psychiatri c disorders in tinnitus patients, and mostly OCD, present in 83% of tinnitus patients.", "A Brazilian study by Mathias et al, (2010)25 also found a very high prevalence of at least one psychiatric diagnosis in tinnitus patients (82% of the patients fulfilled the criteria), and most of the patients had panic disorder (40%). The same prevalence of depression was found, followed by generalized anxiety disorder (34%). A summary of the articles included in this review and its results are described in table 1.", "Discussion Most of the studies included in this review showed a clear correlation between tinnitus severity and the presence of psychiatric disorders and a high prevalence of these diseases and symptoms in tinnitus patients10-17. Most patients are affec ted by mood disorders, and specially depression and anxiety disorders6,10-15,17,23,25 -29. However many other psychiatric diagnoses and s ymptoms may be present and may significantly affect tinnitus severity. Thus, tinnitus has been associated with psychiatr ic disorders, possibly as a cause -and-effect relationship. Despite the high rate for the coincidence of tinnitus and mental disorders, and specially depression and anxiety, a cause cannot be directly established. Severe tinnitus may cause psychological dis comfort because tinnitus is a disturbing problem, or the presence of depression and anxiety may reduce tolerance for tinnitus, causing the symptoms to be overestimated6. Given that tinnitus is a significant stressor, people react differently depending on t heir vulnerability to stress. Tinnitus sufferers may have a particular vulnerability to the stress impact of the tinnitus sound6. A genetic cause of such vulnerability to stress could hypothetically be a shared neurobiological pathway for developing both depression and tinnitus6,10. Comorbid mental disorders are likely the most important factors affecting the disability and suffering in tinnitus patients, as shown by the articles described in this review10. A vicious cycle is usually established in tinnit us patients: tinnitus causes and exacerbates stress, and stress causes and worsens tinnitus. Tinnitus may not always be the starting point of this cycle. Most patients have experienced a certain degree of anxiety and depression before tinnitus began. Howev er, tinnitus can increase the severity of existing psychological disorders or tendencies16.", "When analyzing the strong placebo effect in tinnitus30, studies have shown nearly 40% of tinnitus patients treated with placebo have improvement in the quality of life related to the symptom. We may again conclude that psychological factors play an important modulatory role in shaping the perception of and increasing the distress associated with tinnitus.", "Since the 1990s, studies by Jastreboff et al2 reported the major role of the abnormal activation of the limbic system and the autonomic nervous system in patients who were annoyed, and often completely handicapped by tinnitus. This role is the mechanism underlying the difference between the 80% of patients who onl y experience tinnitus and", "the 20% who suffer from tinnitus. Again, the relationship between tinnitus and emotions is well discribed.", "Currently, most work with tinnitus patients is based on a multidisciplinary approach, especially with collaboration betwee n the otolaryngologist, the audiologist and mental health professionals.", "One aspect of the selected articles that should be carefully observed is that the studies vary greatly in the instruments used to measure tinnitus's impact on patients' lives and to evaluate the psychiatric diagnosis and symptoms. This variation could interfere with comparisons between the studies. Moreover, certain instruments used in psychiatric evaluation can determine psychiatric diagnosis, whereas others demonstrate only the presence of psychiatric symptoms. In our opinion, the MINI could be a good tool as this instrument determines a psychiatric diagnosis and is an easy scale to be trained on, even though the SCID is the gold standard. When evaluating the impact of tinnitus on a patient's life, the THI is the questionnaire recommended by the Tinnitus Research Initiative, because this instrument has been translated into the greatest number of languages.", "Conclusion After evaluating the reviewed articles, we conclude that the preva lence of psychiatric disorders, and especially anxiety and depression, is high in tinnitus patients, and that the presence of these disorders correlates with tinnitus severity and annoyance, resulting in a bigger impact on the patients' quality of life. References 1. Coelho CCB, Sanchez TG, Bento RF. Características do zumbido em pacientes atendidos em serviço de referência. Arq Internacionais Otorrinolaringologia. 2004; 2. Jastreboff PJ, Hazell JWP. A neurophysiological approach to tinnitus: clinical implications. Br J Audiol. 1993; 27(1): 7 -17.", "3. Lynn SG, Bauch CD, Williams DE, Beatty CW, Mellon MW, Weaver AL. Psychologic profile of tinnitus patients using the SCL -90-R and tinnitus handicap inventory. Otol Neurotol. 2003; 24(6): 878 -81.", "4. Unterrainer J, Greimel KV, Leibetseder M, Koller T. Experiencing tinnitus: which factors are important for perceived severity of the symptom? Int Tinnitus J. 2003; 5. Scott B, Lindberg P. Psychological profile and somatic complaints between help - seeking and non help-seeking tinnitus subjects. Psychosomatics. 2000; 41(4): 6. Malakouti SK, Nojomi M, Mahmoudian S, Salehi M. Comorbidity of chronic tinnitus and mental disorders. Int Tinnitus J. 2011; 16(2):118 -22. 7. Sullivan MD, Katon W, Dobie R, Sakai C, Russo J , Harrop -Griffiths. Disabling tinnitus. Association with affective disorders. Gen Hosp Psychiatry. 1988; 8. Harrop -Griffiths J , Katon W, Dobie R, Sakai C, Russo J. Chronic tinnitus : association with psychiatric diagnosis. J Psychosom Res. 198 7; 31 (5): 613 -21. 9. Simpson RB, Nedzelski JM, Barber HO, Thomas MR. Psychiatric diagnoses in patients with psychogenic dizziness or severe tinnitus. J Otolaryngol. 1988; 17(6): 10. Zoger S, Svedlund J, Holgers KM. Relationship between tinnitus severity and psychiatric disorders. Psychosomatics. 2006; 47(4): 282 -88. 11. Holgers KM, Zoger S, Svedlund K. Predictive factors for development of severe tinnitus suffering -further characterization.Int J Audiol. 2005; 44(10): 584 -92. 12. Hérbert S, Canlon B, Hasson D, Han son LLM, Westerlund H, Theorell T. Tinnitus severity is reduced with reduction of depressive mood -a prospective population study in Sweden. PloS One. 2012; 7(5): e37733.", "13. Reynolds P, Gardner D, Lee R. Tinnitus and psychological morbidity: a cross - sectional study to investigate psychological morbidity in tinnitus patients and its relationship with severity of symptoms and illness perception. Clin Otolaryngol 14. Salonen J, Johansson R, Joukamaa M. Alexithymia, depression and tinni tus in elderly people. Gen Hosp Psychiatry. 2007; 29(5):431 -5.", "15. Crocetti A, Forti S, Ambrosetti U, Del Bo L. Questionnaires to evaluate anxiety and depressive levels in tinnitus patients. Otolaryngol Head Neck Surg. 2009; 16. Folmer RL, Griest SE , Martin WH. Obsessive -compulsiveness in a population of tinnitus patients. Int Tinnitus J. 2008; 14(2): 127 -30. 17. Oishi N, Shinden S, Kanzaki S, Saito H, Inoue Y, Ogawa K. Influence of depressive symptoms, state anxiety, and pure -tone thresholds on the tinn itus handicap inventory in Japan. Int J Audiol. 2011; 50(7): 491 -95. 18. Tyler RS, Baker LJ. Difficulties experienced by tinnitus sufferers. J Speech 19. McKenna L, Hallam RS, Hinchcliff R. The prevalence of psychological ldisturb ance in neurotology patients. Clin Otolaryngol Allied Sci. 1991; 16(5): 20. Langguth B, Kleinjung T, Fischer G, et al. Tinnitus severity, depression and the big five personality traits. Prog Brain Res. 2007; 166: 221 -27. 21. Russo J, Katon W, Sullivan M, e t al. Severity of somatization and its relationship to psychiatric disorders and personality. Psychossomatics. 1994; 35(6): 546 -56. 22. Sullivan M, Katon W, Russo J, et al. A randomized trial of nortriptylin for severe chronic tinnitus. Effects on depression, disability and tinnitus symptoms. Arch 23. Bartels H, Middel BL, van der Laan BFAM, Staal MJ, Albers FWJ. The additive effect of co -occurring anxiety and depression on health status, quality of life and coping strategies in help-seeking tinnitus sufferers. Ear Hearing. 2008; 29(6): 947 - 24. Ooms E, Meganck R, Vanheule S, Vinck B, Watelet JB, Dhooge I. Tinnitus severity and the relation to depressive symptoms: a critical study. Otolaryngol 25. Mathias KV, Mezzasalma MA, Nardi AE. Prevalência de transtorno de pânico em pacientes com zumbido. Rev Psiq Clin. 2011; 38(4): 139 -42.", "26. Andersson G, Carlbring P, Kaldo -Sandstrom V, Strom L. Screening os psychiatric disorders via the internet. A pilot study with tinnitus patients. Nord J Psychiatry. 27. Belli S, Belli H, Bahcebasi T, Ozcetin A, Alpay E, Ertem U. Assessment of psychopathological aspects and psychiatric comorbidities in patients affected by tinnitus. Eur Arch Otorhinolaryngol. 2008; 265: 279 -85. 28. Marciano E, Carrabba L, Giannini P, Sementina C, Verde P, Bruno C, Di Pietro G, Ponsillo NG. Psychiatric comorbidity in a population of outpatients affected 29. Adoga AA, Adoga AS, Obindo JT. Tinnitus and the pre sence of co -morbid psychological stress. Nig J Med. 2008; 17(1): 95 -7.", "30. Dobbie RA, Sakai CS, Sullivan MD, Katon WJ, Russo J. Antidepressant treatment of tinnitus patients: report of randomized clinical trial and clinical prediction of", "The Journal of Laryngology and Otology This is to certify that the paper", "“Tinnitus and its association with psychiatric disorders: systematic review ” By: P C L Pinto, C M Marcelos, M A Mezzasal ma, F J V Osterne, M A de M T de Lima, A E Nardi", "From: Laboratory of Panic and Respiration Institute of Psychiatry Federal University of Rio de Janeiro, Av. Venceslau Bras, 71 -Botafogo, Rio de Janeiro, RJ 222900 -140 Brasil was awarded the prize for the b est JLO published", "Review of the year - 2014", "on 30 April 2015", "at Broadway House, London SW1 Guy Kenyon Desmond A Nunez JLO Emeritus Editor Chairman JLO Prize Paper Committee", "4.2) Estudo 2 – publicado na Clinical Pract ice and Epidemiology in Mental Health", "Clin Pract Epidemiol Ment Health . 2018; 14: 264 –269. Tinnitus: The Sound of Stress?", "Patricia Ciminelli ,1,2,* Sergio Machado ,1,3 Manoela Palmeira ,1 Mauro Giovanni Carta ,4 Sarah Cristina Beirith ,2 Michelle Levitan Nigri ,1 Marco André Mezzasalma ,1 and Antonio Egidio Nardi1", "1Laboratory of Panic & Respiration (LABPR), Institute of Psychiatry (IPUB), Feder al University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil 2Lagoa Federal Hospital, Ministry of Health, Rio de Janeiro, Brazil 3Physical Activity Neuroscience, Physical Activity Sciences Postgraduate Program - Salgado de Oliveira University, Niterói, B razil", "4 Universitá degli studi di Cagliari, Italy", "Abstract Background: Emotional stress is frequently associated to otologic symptoms as tinnitus and dizziness. Stress can contribute to the beginning or worsening of tinnitus. Objective: The objective of t he study is to evaluate the presence of stress symptoms in patients with chronic, subjective tinnitus, and correlate its presence to annoyance associated to tinnitus. Methods: Cross -sectional study. One hundred and eighty patients with chronic, subjective tinnitus were included. Patients answered the Tinnitus Handicap Inventory (THI) to evaluate the impact of tinnitus in the quality of life and answered the Lipp's inventory symptoms of stress for adults (ISSL). The data obtained was organized using Excel® 2010, mean values, linear regression and p -value were calculated. Results : Of the 180 patients included in the study, 117 (65%) had stress symptoms, 52 of the 117 (44%) were in the resistance phase and 23 of the 117 (20%) in the exhaustion phase, the rem aining was in the alert phase. There was a clear progressive increase in stress as THI raised, with more impact of tinnitus in quality of life. Conclusion : The presence of stress symptoms, measured by ISSL was observed in", "most of our patients with chronic subjective tinnitus, specially in the resistance and exhaustion phases and it is directly associated to tinnitus annoyance. Key words: tinnitus, psychosocial stress, psychosocial comorbidities, annoyance , stress, psychological 1) Introduction:", "Stress is defined as the result of psychological and physical conditions that threatens the normal functioning of ones body[1]. It is is frequently related to numerous medical conditions, including tinnitus. Stress is associated with events difficult to control or manage, related to social, physical, economic, emotional or occupational demands[2].", "Tinnitus is a very common auditory disorder affecting approximately 10 -15% of the population. Although tinnitus is commonly caused by auditory system damages, the role of emotional and psychological factors inducing and maintaining annoyance has been proven in recent tinnitus studies[3].", "Stress is many times attributed as a cause of tinnitus and we often see in the clinic that patients complain that their tinnitus gets w orse after stressful situations. The evidence that stress is related to tinnitus is based on studies that show high psychiatric comorbidity related to the symptom. About 10 – 60% of chronic tinnitus patients suffer from depressive disorders and 28 –45% prese nt with clinically relevant anxiety symptoms[4,5]. It has been frequently observed that many tinnitus patients present with psychological or psychiatric distress before or during the onset and evolution of tinnitus[6]. Some studies that have used stress qu estionnaires in tinnitus patients found a high prevalence of self reported levels of stress. Gomaa et al found that among 100 patients with tinnitus only 25 didn´t have stress; 44 had mild to moderate stress and 31 severe to extreme levels of stress. There is probably a cause and effect relationship between tinnitus and stress[7].", "The aim of the present study is to evaluate the presence of stress symptoms in patients with chronic, subjective tinnitus, using the Lipp's inventory of symptoms of stress for ad ults (ISSL), as well as to correlate its presence to the annoyance associated to tinnitus, applying the Tinnitus Handicap Inventory (THI). The hypothesis suggested in this cross sectional study is that higher THI scores are correlated with worst stress levels.", "2) Methods:", "One hundred and eighty patients with chronic (for more than 6 months), subjective tinnitus, with ages 27 -79 years were evaluated at a tinnitus clinic in the otorhynolaryngology department at a referral hospital in our city, according to a n established clinical protocol for tinnitus patients. Before agreeing to participate in the study, patients signed the informed consent. The study was approved by the local ethic comitee, approval number 42441514.0.0000.5291. All patients, who were referr ed to our clinic from January 2014 to January 2015, were submitted to routine exams for tinnitus diagnosis and were included in the study. Patients answered the THI and the visual analog scale , to evaluate the impact of tinnitus in the quality of life and answered the ISSL, to evaluate the presence of stress symptoms, which is composed by 37 somatic items and 19 psychological items. These items are organized in three phases of stress: alert, resistance and exhaustion phases. They also answered the Mini International Neuropsychiatric Interview (MINI) Questionnaire v. 5.0 for the investigation of the presence of concomitant psychiatric disorders. The inclusion criteria were:", "- Presence of tinnitus for at least 6 months.", "- Ability to answer the questionnaire s.", "- Patient agreement to participate in this study.", "The exclusion criteria were:", "- Mild and Severe cognitive impairment.", "- Diagnosis of central nervous system tumors, including cerebellum -pontine angle (CPA) tumors.", "- Recent surgery or otologic procedure, including implantable hearing devices. - Presence of psychiatric disorders diagnosed by the MINI Statistical analysis The THI and the ISSL scores in the analysis are reported with mean and standard deviation.", "The level of signific ance used as a reference was set at p ≤ 0.05.", "Inferential statistics were performed using Pearson's correlation performed with the Statistical Package for the Social Sciences 23.0 (SPSS).", "3) Results:", "One hundred and eighty patients were included in the study, 75 (41,6%) male and 105 (58,4%) female. The age ranged from 27 to 79 years, mean 59.86 years (SD 12.5). The time since the beginning of tinnitus was: from 6 months to 4 years in 93 patients (51,6%), from 5 to 10 years in 60 (33,3%) and more than 10 years in 27 (15%) patients. None of the patients had psychiatric disorders nor were taking medications targeting the central nervous system or ototoxic medications.", "The mean THI score was 43.43 (SD 23.99) and the mean visual analog scale score was 6.91 ( SD 14.95). Grade I or slight tinnitus in THI was found in 27 (15%) patients, grade II or mild, in 54 (30%) patients , grade III or moderate, in 42 (23,3%) patients, grade IV or severe, in 39 (21,6%) patients and grade V or catastrophic, in 18 (10%) patient s (Figure 1).", "Of the 180 patients included in the study, 117 (65%) had stress symptoms, 52 (44%) of the 117 were in the resistance phase and 23 of 117 (20%) in the exhaustion phase, the remaining patients were in the alert phase of stress (Figure 2). In the slight tinnitus group, 12 (44.4%) patients had stress symptoms. In the mild tinnitus group of patients, 30 (55.5%) had stress. Thirty three (78,5%) of the patients with grade III tinnitus had stress symptoms; Twenty four (61.5%) in grade IV and all patients (100%) in grade V had stress. We noticed a clear progressive increase in stress as THI gets higher, with more impact in quality of life. The prevalence in each group is represented in figure 3.", "To evaluate the proposed hypothesis (H1) a linear regression with stress being the dependent variable and THI the independent value was done. The p-value found was 0.00576, demonstrating that the higher the annoyance, the more stressed patients are. 4) Discussion:", "The results presented show a high occu rance of stress symtoms in tinnitus patients evaluated in a reference tinnitus clinic, specially in the more advanced phases, the resistance and exhaustion phases. We observed a clear increase in stress symptoms in patients with higher THI scores, being st ress present in all patients with catastrophic", "tinnitus. To our knowledge this is first study in Brazil using a stress scale in tinnitus patients.", "There is enough evidence supporting the understanding that tinnitus induces stress. However, still little is known about stress being responsible for the appearance or worsening of tinnitus. It has been frequently observed that many tinnitus patients present with psychological or psychiatric distress before or during the onset and evolution of tinnitus[8]. Which comes first is still unknown but authors agree that stress is obviously related to tinnitus and directly associated to its annoyance. One of the earliest published studies showing an evidence between the onset of tinnitus to psycho -social distress was m ade by John Harrison Curtis, describing two of five patients that related the beginning of tinnitus to a psycho -social stress caused by death of a close family member, as cited by Baigi et al, 2011[9]. One hundred and seventy years later, two large studies published important epidemiological information concerning the association of psycho -social stress with tinnitus[9,10]. The first study demonstrated that the probability of developing tinnitus is approximately the same for highly stressed persons as it is for persons exposed to occupational noise[9], stress seems as important as auditory damage for causing tinnitus. Importantly, the authors also have noticed that psycho -social stress contributes to worsening of tinnitus symptoms. The studies describe that exposure to high levels of stress and occupational noise, together, doubles the probability of developing tinnitus. In the second study, approximately one - third of working population observed and complained of hearing problems, tinnitus or both. Tinnitus a nd the duration and magnitude of stress were linearly associated[10]. Both studies included more than 10,000 subjects each, which provides great statistical strength relating tinnitus to stress. Mazurek et al[6,11], described higher scores in the “worries” and “tension” subscales of the Perceived Stress Questionnaire in patients with disturbing chronic tinnitus when compared to those with non -disturbing tinnitus. Similarly, in our study 65% of our tinnitus patients had stress symptoms, measured by the Lipp' s Stress Symptoms Scale.", "For many patients, with increased reactivity to stress, tinnitus may work as an alarm signal, at least at its onset, informing the patient that something could be wrong or that something potentially dangerous could be happening an d stress factors are clearly related to this reaction. Aspects concerning this danger alarm and the way patients react to and face the symptom can explain the epidemiological differences between the", "incidence of referred tinnitus (10 –15%) and that of disab ling tinnitus (2%). In other words, tinnitus becomes a disabling symptom in subjects chronically exposed to stress who are unable to switch off the alarm signal or to neutralize the effect of the stressors. In other individuals, the same factors or disease s could provoke tinnitus without inducing annoyance or distress because these subjects are skilled to cope with tinnitus as a stressor, with a real capacity to restore normal body stability. Individual capacity to neutralize stress factors is strictly spe cific for each subject: the progression from alarm to exhaustion stress phases is specific for each patient. In a referral tinnitus clinic one would expect a higher number of patients in resistance and exhaustion phases, as found in our study. It is deman ding to identified the stress signals during the alarm phase to prevent a progression toward the resistance phase and, especially, exhaustion phase. These later phases can lead to chronic disabling tinnitus, in which there is an important emotional -affecti ve activation[12,13].", "Assuming that tinnitus patients have a greater amount of stress reactivity, maladjustment to daily stress situations could be a consequence. It has been demonstrated that decompensated tinnitus patients use more maladaptive coping strategies compared to controls[14,15,16,17]. Concerning the physiological factors, maladaptive stress reactivity in chronic tinnitus patients should lead to an excessive reactivity in the autonomous nervous system. Some studies addressed and evidenced th e role of abnormal physiological stress reactions in the onset and maintenance of tinnitus symptoms[18,19,20]. The high efficacy of psychotherapy in the treatment of tinnitus sufferers argues in favor of stress reactivity related to tinnitus distress[21], considering that most of these treatment programs address coping strategies to stress. Also, studies testing the effect of relaxation training emphasize psychophysiological factors in chronic tinnitus patients[22,23]. Many patients mey also benefir from the use use of drugs targeting the central nervous system in order to reduce anxiety and stress associated symptoms[24].", "The information collected here, indirectly imply the requirement for psychological assessment during the diagnosis of tinnitus patient s. Psychological intervention with a goal of stress -management strategies appears to be an indispensable element in tinnitus treatment, especially important to use in very early stages of tinnitus, before the chronification of plastic changes has taken pla ce, considering that stress is highly associated to tinnitus, as a cause or effect.", "Here we discuss a limitation of our study, the lack of a control group. Our intention was solely to describe the presence of stress and to stratify its stages and correlat e with tinnitus annoyance in a selected group of patients referred to a specialized tinnitus clinic.", "5) Conclusion:", "The presence of stress symptoms, measured by the Lipp's Adult Stress Tinnitus Inventory (ISSL), was observed in the majority of our patient s with chronic subjective tinnitus, specially in the resistance and exhaustion phases and it seems to be directly associated to tinnitus annoyance. There’s a close relationship between psychological disorders, including stress, and the occurance and mainte nance of tinnitus, causing impact on patient's quality of life. This article motivates professionals to consider stress an important symptom to be diagnosed and treated in tinnitus patients. 6) Conflict of interest:", "The authors declare that there are n o conflict of interests. References:", "[1] Lipp MEN. O Stress no Brasil: pesquisas avançadas. Campinas: Papirus. 2004. [2]Colman AM. Oxford Dictionary of Psychology. Oxford: Oxford University Press. [3] Heinecke K, Weise C, Schwarz K, Rief W. Physiolog ical and psychological stress reactivity in chronic tinnitus. J Behav Med. 2008; 31(3):179 -88. [4] Andersson G. Psychological aspects of tinnitus and the application of cognitive - bahavioral therapy. Clin Psychol Rev. 2002; 22(7):977 -90. [5] Reynolds P, Gar dner D, Lee R. Tinnitus and psychologial morbidity: a cross - sectional study to investigate psychological morbidity in tinnitus patients and its relationship with severity of symptom and illness perception. Clin Otolaryngol Allied [6] Mazurek B, Haupt H, Joachim R, Klapp BF, Stover T, Szczepek AJ. Stress induces transient auditory hypersensitivity in rats. Hear Res. 2010; 259(1 -2):55 -63.", "[7] Gomaa MA, Elmagd MH, Elbadry MM, Kader RM (2014) Depression, anxiety and stressscale in patie nts with tinnitus and hearing loss. Eur Arch Otorhinolaryngol 2014; [8] Mazurek B, Haupt H, Olze H, Szczepek AJ. Stress and tinnitus -from bedside to bench and back. Front Syst Neurosci. 2012; 6:47 -55.", "[9] Baigi A, Oden A, Almlid -Larsen V, Barr enasML, Holgers KM. Tinnitus in the general population with a focus on noise and stress: a public health study. Ear Hear. [10] Hasson D, Theorell T, Wallén MB, Leineweber C, Canlon B. Stress and prevalence of hearing problems in the Swed ish working population. BMC Public Health. 2011; [11] Mazurek B, Olze H, Haupt H, Szczepek AJ. The more the worse: the grade of noise induced hearing loss associates with the severity of tinnitus. Int J Environ Res Public [12] Alpini D, Cesarani A: Tinnitus as an alarm bell: stress reaction tinnitus model. ORL J Otorhinolaryngol Relat Spec. 2006, 68 (1): 31 -36. [13] Alpini D, Cesarani A, Hanh A. Tinnitus school: an educational approach to tinnitus managementbased on a stress -reaction tinnitus model. Int Tinnitus J. 2007; 13(1): 63 -8. [14] Budd RJ, Pugh R. Tinnitus coping style and its relationship to tinnitus severity and emotional distress. J Psychosom Res. 1996; 41(4): 337 -45. [15] Budd PJ, Pugh R. The relationship be tween locus of control, tinnitus severity and emotional distress in a group of tinnitus sufferers. J Psychosom Res. 1995; 39(8):1015 - [16] Kirsch CA, Blanchard EB, Parnes SM. Psychological characteristics of individuals high and low in their ability to c ope with tinnitus. Psychosom Med. 1989; 51(2):209 -17. [17] Schmitt C, Patak M, Kroner -Herwig B. Stress and the onset of sudden hearing loss and tinnitus. Int Tinnitus J. 2000; 6(1):41 -9.", "[18] Horner KC. The emotional ear in stress. Neurosci Biobehav Rev. 2003; 27(5):437 -", "[19] Sahley TL, Nodar RH. A biochemical model of peripheral tinnitus. Hear Res. [20] Datzov E, Danev S, Haralanov H, Naidenova V, Sachanska T, Savov A. Tinnitus, heart rate variability and some biochemical indicato rs. Int Tinnitus J. 1999; 5(1):20 -3. [21] Andersson G, Lyttkens L. A meta -analytic review of psychological treatment for [22] Weber C, Arck P, Mazurek B, Klapp BF. Impact of a relaxation training on psychometric a nd immunologic parameters in tinnitus sufferers. J Psychosom Res. [23] Rief W, Weise C, Kley N, Martin A. Psychophysiologic treatment of chronic tinnitus: a randomized clinical trial. Psychosom Med. 2005; 67(5):833 -8. [24] Fornaro M, M artino M. Tinnitus psychopharmacology: A comprehensive review of its pathomechanisms and management. 2010; 6: 209 -18.", "4.3) Estudo 3 – publicado na JAMA otorrhynolaringology JAMA Otolaryngol Head Neck Surg. 2016 Feb;142(2):194 -5. doi: Repetitive Transcranial Magnetic Stimulation and Tinnitus -Still a Noisy Issue. Ciminelli P , Machado S , Nardi AE .", "Letter to the editor Regarding the randomized clinical trial by Folmer et al1, recently published, using 1Hz-rTMS applied to the temporal cortex in tinnitus patients for 10 days comp ared to placebo, the authors reported a significant reduction in tinnitus symptoms, the primary outcome measure. However, rTMS for tinnitus is still not significantly beneficial, so we have some considerations to share:", "Most of the randomized, sham co ntrolled studies on rTMS for chronic tinnitus used similar, short protocols: low frequency stimulation to the temporal cortex for 10 days or less (5 days), with some benefit in tinnitus severity and annoyance reduction, but high interindividual variability and moderate effect; almost all agree that different stimulation protocols are necessary for improvements in results.", "Few randomized placebo controlled trials used a rTMS protocol to the temporal cortex for 4 weeks. Piccirillo et al, 20132 found no be nefit of active stimulation when compared to placebo. Other 4 -week treatment protocols would be necessary to determine benefits. Also relevant is the involvement of areas of the brain with abnormal function other than the auditory cortex. The prefront al cortex is one of these areas and Langguth et al, 20124 conducted a randomized placebo controlled rTMS study using a combined stimulation protocol to the auditory cortex (1 Hz) and the left dorsolateral prefrontal cortex (20 Hz) with a secondary outcome favoring active stimulation over placebo. Also De Ridder et al, 20133 stimulated the right dorsolateral prefrontal cortex (1 Hz vs 10 Hz stimulation) with some improvement in the 1 Hz group.", "In rTMS for depression, over 89 individual trials and 4 diff erent large multisite trials have been conducted, and all found statistically and clinically significant effects of daily prefrontal rTMS for 3 –6weeks compared to sham. Data indicate that rTMS therapeutic effects likely develop over several weeks5. Consequ ently, many of the initial trials, which lasted only 1 – 2 weeks, were probably too brief to generate maximum antidepressant effects. It seems that the more the patient is stimulated, the bigger is the benefit. Maybe for tinnitus, as well, most of the studi es have not reached the best possible results because of short stimulation protocols.", "Thus we emphasize the need for more rTMS studies with different protocols to optimize results for tinnitus treatment. Longer treatments, at least 4 weeks, and differ ent sites stimulation should be considered for future studies.", "References 1) Folmer RL, Theodoroff SM, Casiana L, Shi Y, Griest S, Vachhani J. Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus: A Randomized Clinical Trial. JAMA O tolaryngol Head Neck Surg. 2015 Aug 1;141(8):716 -22. 2) Piccirillo JF, Kallogjeri D, Nicklaus J, Wineland A, Spitznagel EL Jr, Vlassenko AG, Benziger T, Mathews J, Garcia KS. Low-frequency repetitive transcranial magnetic stimulation to the temporoparieta l junction for tinnitus: four -week stimulation trial. JAMA Otolaryngol Head Neck Surg. 2013 Apr;139(4):388 -95.", "3) De Ridder D, Song JJ, Vanneste S. Frontal cortex TMS for tinnitus. Brain 4) Langguth B, Landgrebe M, Frank E, S checklmann M, Sand PG, Vielsmeier V, Hajak G, Kleinjung T. Efficacy of different protocols of transcranial magnetic stimulation for the treatment of tinnitus: Pooled analysis of two randomized controlled studies. World J 5) P.M. Rossini, D. Burke, R. Chen, L.G. Cohen, Z. Daskalakis, R. Di Iorio, V. Di Lazzaro, F. Ferreri, P.B. Fitzgerald, M.S. George, M. Hallett, J.P. Lefaucheur, B. Langguth, H. Matsumoto, C. Miniussi, M.A. Nitsche, A. Pascual -Leone, W. Paulus, S. Rossi, J.C. Rothwell, H.R. Siebner, Y. Ugawa, V. Walsh, U. Ziemann. Non-invasive electrical and magnetic stimulation of the brain, spinal cord, roots and peripheral nerves: Basic principles and procedures for routine clinical and research application. An", "updated report from an I.F.C.N. Committee. Clinical Neurophysiology 126 (2015)", "4.4) Estudo 4 – publicado na Eurasian Journal of Medicine", "Published online 2018 Apr 8. doi: 10.5152/eurasianjmed.2018.18073 Bilateral Dorsomedial Prefrontal Cortex rTMS for Tinnitus Treatment: A Successful Case Patricia Ciminelli ,1 David Sender ,2,3 Manoela Palmeira ,1 Marco An dré Mezzasalma ,1 Arnaldo Cascardo ,1 Sergio Machado ,1,3 and Antonio Egidio Nardi1", "1Laboratory of Panic & Respiration (LABPR), Institute of Psychiatry (IPUB), Feder al University of Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil", "2Juiz de Fora Federal University", "3Physical Activity Neuroscience, Physical Activity Sciences Postgraduate Program - Salgado de Oliveira University, Niterói, Brazil Abstract We describe a succes sful tinnitus treatment case, with intensity and distress reduction, in patient submitted to bilateral 10Hz repetitive transcranial magnetic stimulation (rTMS) to dorsomedial prefrontal cortex (DMPFC). Subjective tinnitus is the perception of sound in ear s or head when no corresponding external stimulus exists. Approximately 1 -2% of the population report severe tinnitus, with daily life impairment. S ham-controlled studies reveal benefits using rTMS in tinnitus, although improvement is moderate or temporary , indicating need for new strategies. Evidence that DMPFC is important in tinnitus pathophysiology make this area a promising target. A 51 year -old male patient with 4 - year history of treatment -resistant moderate bilateral tinnitus was treated with 20 sess ions of bilateral 10Hz DMPFC rTMS. Patient presented important reduction and sustained 4 month response in tinnitus loudness and annoyance, 24 point drop in tinnitus handicap inventory, visual analog scale reduction to zero and tinnitus loudness of 1dB, co mpared to baseline 15dB. Tinnitus treatment is hard and new alternatives are needed. To our knowledge, this is the first report using rTMS in DMPFC for tinnitus. In this protocol, important and sustained reduction of tinnitus annoyance and loudness was obt ained. This", "case suggest this approach promising for treating tinnitus and is worth further investigation.", "Key words: tinnitus, prefrontal cortex, transcranial magnetic stimulation Introduction In this report, we describe a case of success, with a reducti on in tinnitus intensity and distress, in a patient submitted to bilateral high frequency rTMS to the dorsomedial prefrontal cortex (DMPFC).", "Subjective tinnitus is characterized by the perception of sound in the ears or head when there is no corresponding external stimulus. About 5 to 15% of the adult population perceive these sounds chronically. Approximately 1 -2% of the general population report severe tinnitus, associated with impact in daily life. Despite the great amount of literature concerning tinnit us treatment, there are still no evidence -based established treatments for curing tinnitus or for effectively reducing its intensity [1].", "Some Sham -controlled studies revealed beneficial effects using repetitive transcranial magnetic stimulation (rTMS) in the treatment of tinnitus. But, still, results show only moderate or temporary improvement and high variability between individuals. New strategies, focusing different brain areas related to tinnitus should be tested and evaluated in new studies[2 -3]. The subcallosal area, containing the medial prefrontal (dorsal and ventral) and anterior cingulate cortices, has been implicated in tinnitus pathophysiology, according to neuroimaging studies, making this area a potential target for tinnitus treatment with rT MS [4 -5]. The use of DMPFC rTMS has been described in the treatment of other disorders and, recently, in patients with major depression in borderline personality disorder, a report of three cases, with successful results [6]. Given the scientific backgrou nd, we experimented a new rTMS protocol with promising results as described in the following case.", "Case Presentation Patient provided written informed consent. The study was approved by ethics committee (protocol CAEE 48853015.6.0000.5263). A 51 year -old caucasian male, engineer, presenting continuous, bilateral, symmetric tinnitus for 4 years, already treated with pharmacological interventions and tinnitus retraining therapy with no reduction in", "tinnitus intensity or annoyance . The tinnitus worsened wit h stress and in silent environment. The patient had no dizziness, hearing loss or fulness in the ears. He had good health, didn't use any medication regularly and had no complaints of pain in the head or neck. Otolaryngological clinical exam was normal and so were audiometric and laboratory tests.", "The Mini International Neuropsychiatric Interview (MINI) v 5.0 revealed no concomitant psychiatric disorders. The symptom was measured using the Tinnitus Handicap Inventory (THI) and visual analog scale (VAS), tin nitus pitch matching (PM), loudness matching (LM) and minimal masking level (MML) at baseline, 2 weeks, 1 and 4 months after treatment.", "The rTMS protocol consisted of 10 Hz stimulation at 120% of the resting motor threshold of the extensor hallucis longu s. Each session of 10 Hz stimulation applied 3000 pulses to each hemisphere non -simultaneous (6000 pulses total), a duty cycle of 5 seconds on and 10 seconds off, for a total stimulation time of 30 minutes, 5 times a week, consecutively, for 4 weeks, over bilateral DMPFC (Fz electrode site in the 10/20 International EEG system, corresponding to the 25% of the nasion -inion distance ), using the fluid -cooled figure 8 coil (Neurosoft, Neuro -MS/D device). Baseline, 2 -weeks, 1 and 4 -month follow -up THI and VAS s cores and tinnitus loudness and MML are presented in Table 1. At baseline the patient had moderate tinnitus, grading 38 in THI and 7 in VAS. After 4 weeks of rTMS, the patient effectively responded to treatment, as indicated by a drop greater than 20 point s in the THI, a reduction of VAS to 0, and MML and tinnitus loudness reduction to 1dB, compared to 18 and 15dB, respectively, at baseline. There were no reported side effects after rTMS. At 4 months the patient displayed sustained remission.", "Discussion To our knowledge, this is the first report of the use of rTMS targeting the DMPFC to treat tinnitus. The treatment of tinnitus is notoriously hard and new alternatives are ghastly needed. In our report, the patient presented an important and sustained reduc tion of his tinnitus after bilateral DMPFC -rTMS. Our findings suggest that rTMS targeting the medial prefrontal cortex, specifically the DMPFC, may represent a safe and tolerable therapeutic alternative for tinnitus treatment. E vidence shows that tinnitus patients exhibit", "significantly less gray matter (GM) volume in ventromedial prefrontal cortex (VMPFC) compared to control participants as well as in DMPFC [4]. Studies identified that the GM reductions in the DMPFC correlated directly with the percentage o f time participants were aware of their tinnitus. Thus, patients with bigger cortical sulci were aware of their tinnitus more often than those with DMPFC gyrificiation similar to control participants, suggesting that this area may play an important role in tinnitus [5]. In a study using voxel - based morphometry, there was evidence of significant volume loss in the subcallosal area (which includes the DMPFC) in tinnitus patients [7]. Thus, t he subcallosal area may be considered as a major hub linking limbic -affective systems with thalamo -cortical system. The first clinical study with tinnitus patients stimulated in deeper brain areas was published by Vanneste et al. [8] applying double -cone -coil (DCC) rTMS to the medial frontal cortex of 78 patients, showin g improvement depending on the frequency of the stimulation. A second study with 73 patients was published reporting differences between single session and repeated sessions of 1Hz DCC TMS prefrontal stimulation (anterior cingulate cortex) for tinnitus tre atment. Both single sessions and multiple sessions suppressed tinnitus distress and intensity transiently. Multiple sessions generated a higher suppression effect in more patients when comparing to single session [9]. A randomized, double -blind pilot tri al with 40 patients suffering from chronic tinnitus compared mediofrontal stimulation with DCC, (10Hz) combined with left temporo -parietal stimulation with figure -of-eight -coil (1Hz) to left dorsolateral - prefrontal -cortex stimulation with figure -of-eight -coil (10Hz) combined with temporo - parietal stimulation with figure -of-eight -coil (1Hz). The combination of mediofrontal/temporoparietal -rTMS failed to show better outcome when compared to the group dorsolateral prefrontal/temporo -parietal[10].", "Conclusion The impressive result of this case, with important and sustained reduction of tinnitus annoyance and loudness in a previously treated patient, suggests that rTMS of the DMPFC is a promising approach for the treatment of tinnitus and is worth further investi gation. Coil placement is simple and can be accurately achieved without MRI guidance. Even though the DMPFC lies 3 -4cm deep, the figure of eight coil can stimulate this area when the motor threshold of the extensor hallucis longus is found [11]. Given this report, it can now be said that r andomized sham -controlled trials to assess the efficacy", "of DMPFC -rTMS in tinnitus are important and could drastically improve patient's treatment safely and effectively.", "References 1) Tunkel DE, Bauer CA, Sun G H, et al. Clinical practice guidelines: tinnitus. Otolaryngol Head Neck Surg. 2014; 151: 1 -40.", "2) Langguth B, Langrebe M, Frank E, et al. Efficacy of different protocols of transcranial magnetic stimulation for the treatment of tinnitus: Pool ed analysis of two randomized controlled studies. World J Biol Psychiatry. 2014; 15: 276 –85. 3) Soleimani R, Jalali MM, Hasandokht T. Therapeutic impact of repetitive transcranial magnetic stimulation (rTMS) on tinnitus: a systematic review and meta -analysis. Eur Arch Otorhinolaryngol. 2015; 273: 1663 -75. 4) Leaver AM, Seydell -Greenwald A, Rauschecker JP. Auditory -limbic interactions in chronic tinnitus: Challenges for neuroimaging research. Hear Res. 2016; 334: 5) Rauschecker JP, Leaver A., Muhlau M. Tuning out the noise: Limbic -auditory interactions in tinnitus. Neuron. 2010; 66: 819 -26.", "6) Feffer K, Peters SK, Bhui K, Downar J, Giacobbe P. Sucessful dorsomedial prefrontal cortex rTMS for major depression in borderline personality disorder: three cases. Brain S timul. 2017; 10:716 -7 7) Muhlau M, Rauschecker JP, Oestreicher E, et al. Structural brain changes in tinnitus. Cereb Cortex 2006; 16(9): 1283 -8.", "8) Vanneste S, Plazier M, Van de Heyning P, De Ridder D. Repetitive transcranial magnetic stimulation frequency depen dent tinnitus improvement by double cone coil prefrontal stimulation. J Neurol Neurosurg Psychiatry. 2011; 82:1160 –4. 9) Vanneste S, De Ridder D. Differences between a single session and repeated sessions of 1 Hz TMS by double -cone coil prefrontal stimulation for the improvement of tinnitus. Brain Stimul. 2013; 6: 155 –9. 10) Kreuzer PM, Lehner A, Schlee W, et al. Combined rTMS treatment targeting the anterior cingulate and the temporal cortex for the treatment of chronic tinnitus.", "11) Deng ZD, Lisanby SH, Peterchev AV. Coil design considerations for deep transcranial magnetic stimulation. Clin Neurophysiol. 2014; 125: 1202 -12.", "4.5) Estudo 5 : publicado na revista Ear and Hearing print.", "Dorsomedial prefrontal cortex rTMS for tinnitus: promissing results of a blinded sham controlled study Patricia Ciminellia,1 – Otolaryngologist – corresponding author patriciaciminelli@gmail.com Sergio Machadob – Neuroscientist – secm80@gmail.com Manoela Palmeiraa – Otolaryngologist – manoelapalmeira@hotmail.com Evandro Silva Freire Coutinhoc,d – MD, PhD, professor I-A CNPq researcher – esfcoutinho@gmail.com David Sendere – Psychiatrist – davidsender@gmail.com Antonio Egidio Nardia – MD, PhD, Psyc hiatrist, Full professor of psychiatry – antonioenardi@gmail.com", "a Laboratory of Panic and Respiration (LABPR), Institute of Psychiatry (IPUB), Federal University of Rio de Janeiro (UFRJ), Brazil. Rua Venceslau Brás, 71 Botafogo, Rio de Janeiro – RJ, Braz il 22290 -140 bPhysical Activity Neuroscience, Psysical Activity Sciences Postgraduate Program, Salgado de Oliveira University, Niterói, Brazil. Rua Mal. Deodoro, 217 - Bloco A - Centro, Niterói – RJ, Brazil 24030 -060 cNational School of Public Health – Fundação Oswaldo Cruz (FIOCRUZ), Brazil. Av. Brasil, 4036 - Manguinhos, Rio de Janeiro - RJ, 21041 -361 dInstitute of Social Medicine – Rio de Janeiro´s State University (UERJ), Brazil . Rua São Francisco Xavier 524 – Maracanã, Bloco D, 7º andar . Rio de Janei ro – RJ – 20550 - e Juiz de Fora Federal University (UFJF), Juiz de Fora, Minas Gerais, Brazil. Rua José Lourenço Kelmer, s/n - São Pedro, MG, 36036 -900", "Abstract Objective : Tinnitus is the perception of sound in ears or head without corresponding exter nal stimulus. Despite the great amount of literature concerning tinnitus treatment, there are still no evidence -based established treatments for curing or for effectively reducing tinnitus intensity. Sham -controlled studies revealed beneficial effects usin g repetitive transcranial magnetic stimulation (rTMS). Still, results show moderate, temporary improvement and high individual variability. S ubcallosal area (ventral and dorsomedial prefrontal and anterior cingulate cortices) has been implicat ed in tinnitu s pathophysiology. Our objective is to e valuate the use of bilateral, high frequency dorsomedial prefrontal cortex (DMPFC) rTMS in treatment of chro nic subjective tinnitus. Design : Randomized placebo controlled, blinded clinical trial. Twenty sessions of bilateral, 10Hz rTMS at 120% of resting motor threshold of extensor hallucis longus was applied over the DMPFC. Fourteen patients underwent sham rTMS and 15 were submitted to active stimulation . Tinnitus Handicap Inventory (THI), visual analog scale (VAS) a nd tinnitus loudness matching were obtained at baseline and on follow up visits. The impact of intervention on outcome measures was evaluated using a regression model for longitudinal data. Results : 11.52 point reduction in THI scores is observed in active group (95% IC: -23.1 a 0.0; p=0.05). Tinnitus loudness matching also shows advantage in active group, reduction of 4.46 dB (95% CI: -9.60 a 0.68 dB, p=0.09). Conclusion : Tinnitus treatment with high frequency, bilateral, DMPFC rTMS was effective in reduci ng tinnitus annoyance measured by THI and tinnitus loudness when compared to sham stimulation.", "Key words: Tinnitus; repetitive transcranial magnetic stimulation; rTMS; dorsomedial prefrontal cortex Approved by the Brazilian Clinical Trials Registration (Re BEC) under the number RBR -", "748nrs", "Introduction Subjective tinnitus is characterized by the perception of sound in the ears or head when there is no corresponding external stimulus. About 5 to 15% of the adult population perceive these sounds chronically. Ap proximately 1 -2% of the general population report", "severe tinnitus, associated with significant impact in daily life (Jastreboff & Hazell 1993; Onishi et al. 2018) . Despite the great amount of literature concerning tinnitus treatment, there are still no evidence -based established treatments for curing tinnitus or for effectively reducing its intensity (Tunkel et al. 2014) .", "Modern neurophysiological and neuroimaging techniques helped to understand the abnormal functioning of the central nervous system in patients with chronic subjective tinnitus (Lanting et al. 2009; Schlee et al. 2008; De Ridder et al. 20 13). Tinnitus is associated with functional changes in central auditory and non -auditory pathways, as well as dysfunctional connectivity between these areas (Møller 2011; Eggermont & Roberts 2012; Leaver et al. 2011; Seydell -Greenwald et al . 2012) . Changes in activity in temporal, frontal, parietal and limbic areas associated with tinnitus seem to reflect these pathologic abnormalities (Seydell -Greenwald et al. 2012; Leaver et al. 2016a; Rauschecker et al. 2010; Raus checker et al. 2015; Landgrebe et al. 2009; Maudoux et al. 2012; Mirz 2000; Ueyama et al. 2013) .", "Sham -controlled studies revealed beneficial effects using repetitive transcranial magnetic stimulation (rTMS) in the treatment of tinnitus (Plewnia et al. 2007; Rossi et al. 2007; Smith et al. 2007; Lehner et al. 2016; Langguth et al. 2014; Kreuzer et a l. 2011; Folmer et al. 2015) . But, still, results show only moderate or temporary improvement and high variability between individuals. New strategies, focusing different brain areas related to tinnitus should be tested and evaluated in new studies (Kreuzer et al. 2011; Folmer et al. 2015) . The subcallosal area, containing the me dial prefrontal (dorsal and ventral) and anterior cingulate cortices, has been implicated in tinnitus pathophysiology, according to neuroimaging studies, making this area a potential target for tinnitus treatment with rTMS (Leaver et al. 2016a; Seydell - Greenwald et al. 2012; Leaver et al. 2011; Rauschecker et al. 2010; Leaver et al. 2016b) . The use of dorsomedial prefrontal cortex (DMPFC) rTMS has been described in the treatment of other disorder s, as major depression, with successful result (Downar & Daskalakis 2013; Bakker et al. 2015) .", "Given the need for new tinnitus treatment and to optimize tinnitus rTMS protocols, considering the involvement of the medi al frontal cortices in tinnitus pathophysiology and based on the successful results with DMPFC rTMS to treat depression, the objective", "of our study is to evaluate the use of bilateral, high frequency DMPFC rTMS in the treatment of chronic subjective tinnit us.", "Materials and Methods:", "A randomized placebo controlled, blinded clinical trial was conducted to evaluate the effects of bilateral, high frequency rTMS over the DMPFC on the treatment of chronic subjective tinnitus from January 2018 until December 2018 . The study was approved by the local ethics committee under the number CAEE 48853015.6.0000.5263 and registered and approved by the Brazilian Clinical Trials Registration (ReBEC) under the number RBR -748nrs. All patients signed a written informed consent before entering the trial. Sample and baseline evaluation:", "A total of 48 patients were accessed to be included in the study. Eight of these did not meet the inclusion criteria and four did not want to participate for different reasons. The inclusion crit eria were as follows: patients from both genders with age ranging 20 - 80 years, diagnosis of tinnitus for at least 3 months and for 5 years at the most, with moderate severity (a minimum of 38 points in the Tinnitus Handicap Inventory), without associated p sychiatric disorders, according to DSM -V. Hearing had to be normal or sensorineural hearing loss compatible with age (age -adjusted, not more than 5 dB below the 10% percentile according to DIN EN ISO 7029) (Anon 2017; Valiente et al. 2015) . Exclusion criteria were: conductive hearing loss (outer and middle ear disease), objective tinnitus, somatossensory tinnitus, patients taking medication acting in the central nervous system, othe r current tinnitus treatment, contra indications for rTMS. Patients could not have been submitted to rTMS to ensure blinding of the study.", "Thirty six patients were randomized, using a computer generated randomization list in Microsoft Excel®•, to enter th e study. Seven patients dropped out in different stages of the study. Our final sample was composed of 29 patients, between 47 and 78 years of age, randomized into two groups: sham and active. Fourteen patients underwent sham stimulation (group 0) and 15 w ere submitted to active rTMS stimulation (group 1). A baseline visit was performed 7 days before the beginning of rTMS sessions. During this visit patients underwent a full otolaryngology appointment, answered tinnitus scales (Tinnitus Handicap Inventory – THI and the visual analog scale on tinnitus annoyance – VAS), in order to evaluate tinnitus severity; completed the Mini Neuropsychiatric", "Interview (MINI v5.0) to exclude psychiatric disorders and were submitted to a complete audiometric exam (bone and ai r conduction tonal and vocal audiometry) and tinnitus pitch matching, loudness matching and minimal masking level measurement to estimate tinnitus parameters (Momensohn -Santo, T.M.; Russo 2013; Henry & Meikle 2000; Mohan et al. 2016) .", "The rTMS protocol:", "The rTMS pro tocol consisted of 10 Hz stimulation at 120% of the resting motor threshold of the extensor hallucis longus (defined as the minimal intensity to move the hallucis longus five out of ten times, when stimulated). Each session of 10 Hz stimulation applied 300 0 pulses to each DMPFC (Fz electrode site in the 10/20 International EEG system, corresponding to the 25% of the nasion -inion distance ) (Mir-Moghtadaei et al. 2016) , non -simultaneously (6000 pulses total), a duty cycle of 5 seconds on and 10 seconds off, for a total stimulation time of 30 minutes, 5 times a week, co nsecutively, for 4 weeks, using the fluid -cooled figure 8 coil (Neurosoft, Neuro -MS/D device). The sham group received the same protocol using a placebo figure of eight coil. The coil was supported over the skull using a mechanical arm (Neurosof t-Equipamen tos Médicos, Brasil – Rua das Folhagens, 364 Campo Grande MS, Brazil ) and the patients were seated comfortably in a reclining chair.", "Assessment and follow up:", "The tinnitus scales (THI and VAS) and tinnitus measures (pitch and loudness matching and minim al masking level measure) were obtained at baseline and on follow up visits at 1 week, 2, 4 and 16 weeks after the end of the 4 weeks of rTMS treatment. Tinnitus measures were performed in a sound proof booth. Pitch matching was obtained using sounds from 250 to 12500Hz and loudness was measured in a 1dB stepwise increase from the patients hearing threshold for the specific tinnitus pitch until the intensity was the same as that of the tinnitus. Loudness was measured in the contralateral ear in cases of uni lateral tinnitus or contralateral to the worse tinnitus side in bilateral asymmetric cases. For bilateral symmetric tinnitus and hearing we always measured using the sound on the right ear (Henry 2016; Henry & Meikle 2000) . Minimal masking level was obtained on the opposite ear of that used for loudness and the intensity desired was when", "the minimal sound necessary to completely mask the tinnitus was achieved. All measures were performed and confirmed t hree times and an arithmetic mean was obtained for the final result.", "Statistical Analysis The distribution of the socio -demographic variables were calculated in both groups (active and sham) to describe the sample and to evaluate the balance achieved by randomization.", "The impact of the intervention on the three outcomes of interest (THI, tinnitus loudness and VAS) was evaluated using a regression model for longitudinal data (repeated measures) using the information collected from baseline and from the fo ur follow up visits after the end of treatment (1,2,4 and 16 weeks) using Stata 14.0 statistic package. The results were considered statistically significant with p values ≤ 0.05 , and of borderline significance when the p -values were between 0.06 and 0.10 . The d -Cohen for the effect size was calculated to evaluate the difference between the groups using the measures from the last follow up evaluation, at 16 weeks. Results:", "The final sample was composed of 29 patients as demonstrated in Figure 1 (CONSORT Flow chart).", "CONSORT 2010 Flow Diagram", "Figur", "Figure 1. Sample distribution according to CONSORT 2010 flow diagram. Assessed for eligibility (n= 48 ) Excluded (n= 12 )  Not meeting inclusion criteria (n= 8 )  Declined to participate (n= 2 )  Other reasons (n= 2) Analysed (n= 15 )  Excluded f rom analysis (give reasons) (n=0 ) Lost to follow -up (give reasons) (n= 0 ) Discontinued intervention (n=3; 2 pain during procedure, 1 abandoned )", "Allocated to active intervention (n=18 )  Received allocated intervention (n= 18 )  Did not receive allocated intervention (give reasons) (n= 0 ) Lost to follow -up (give reasons) (n= 0 ) Discontinued intervention (n= 4; 1 fear of adverse events, 3 abandoned, far from home to attend everyday ) Allocated to sham (placebo) (n= 18 )  Received allocated intervention (n= 18 )  Did not receive allocated intervention (give reasons) ( n=0 ) Analysed (n= 14 )  Excluded from analysis (give reasons) (n= 0) Allocation Analysis Follow -Up Randomized (n= 36 ) Enrollment", "Table 1 describes the demographic and clinical characteristics in the active and sham groups . An unbalanc e in the variables gender and age can be observed; there is a greater proportion of women and yo unger individuals in the active group . No relevant differen ces are seen in the other variables .", "Variable Active intervention N (%) Sham Gender Male Female Age (years) Education Elementary completed High school completed College degree", "Tinnitus side Bilateral Head Right ear Left ear Dizziness No Yes Ocasionaly Time since beginning (*) mean and standard deviation. Table 1. Demographic and clinical character istics of the sample, by group.", "Comparing the THI scores betwe en the two groups, an 11.52 point reduction is observed in favor of the active rTMS group (95% IC: -23.1 a 0.0; p=0.05) , controlling for gender and age . Figure 2 shows the smooth ed trajectorie s of the scores for both groups . An estimate of d -Cohen (“effect -size”) using the comparison between the mean values of the last follow up visit, at 16 weeks after the end of the treatment , was 0.88, and can be interpreted as a strong effect.", "The ana lysis of tinnitus loudness matching also shows advantage in favor of the active group , with a reduction of 4. 46 dB ( 95% CI: -9.60 a 0.68 dB, p=0.09) , data adjusted for gender and age . Figure 3 shows the smoothed trajectories of the values for both groups.", "The d -Cohen (“effect -size”) estimate, using the comparison between the mean values of the last follow up visit (16 weeks after end of the rTMS sessions) was 1. 04, which can be interpreted as a strong effect.", "As for tinnitus annoyance, measured by the visual analog scale (VAS), the data show no statistical ly significant difference between the active and sham groups ( -0.95 95% IC: -2.21 a 0.30, p=0.13), even when adjusted for gender and age . Attention should be made to the great variability between indi viduals on these scores. For a mean reduction of -0.95, the standard deviation was 0.64. These findings are exposed on figure 4.", "Discussion:", "This is the first study to evaluate the effects of rTMS delivered to the dorsomedial prefrontal cortex. The re sults of our study show benefit with the use of bilateral, 4 week long, 10Hz DMPFC rTMS for the treatment of tinnitus. A significant reduction of the THI scores (p=0.05) in the active group and a borderline significant reduction of tinnitus loudness (p=0.0 9), with a strong effect size, on both measures, were observed. Despite the optimistic results regading rTMS to treat tinnitus (Folmer et al. 2015; Mennemeier et al. 2013; Langguth et al. 2007; Kleinjung et al. 2005) , the studies show a great variability in indivi dual responses to treatment as well as moderate benefits. Literature suggests optimizing protocols and testing new strategies to be used clinicaly (Kreuzer et al. 2011; Folmer et al. 2015) .", "Our study uses a different rTMS protocol based on the evidence of the envolvement of the medial prefrontal cortices in tinnitus pathophysiolog y and on studies using rTMS to treat depression using longer treatment periods (4 -6weeks), with more than 1000 pulses per session and intensity higher than 100% of the motor threshold, which", "can increase significantly the number of responders (Berlim et al. 2013b; Berlim et al. 2013a) and stimulating the DMPFC with a figure of eight coil (Downar & Daskalakis 2013; Bakker et a l. 2015; Mir -Moghtadaei et al. 2016) (Deng et al. 2014) . Many studies using rTMS to treat tinnitus have used low frequency stimulation protocols on the temporoparietal cortex (TPC), 5 to 10 sessions, and a reduction in tinnitus severity and annoyance could be observed when compared to sham stimulation (Plewnia et al. 2007; Rossi et al. 2007; Smith et al. 2007) . May et al (May et al. 2007) demonstrated, in neuroimaging studies, that low frequency TPC rTMS is capable of producing deep brain changes in functionaly connected auditory and non auditory areas. In that way, the benefit of superficial stimulations could be also happening because of their aditional deep brain effect. Langguth et al also observed alteration of cortical excitability in low frequency rTMS on the TPC, sugesting improvement in of subcortical inhibitory fu nction (Langg uth et al. 2007) . Folmer et al (Folmer et al. 2015) in a randomized clinical trial also found benefit using 10 sessions of 1Hz rTMS on the TPC in tinnitus severity with a sustained response after 26 weeks of follow up, like our results, with a sustained benefit. Kleinjung et al also demonstrated a highly significant improvement in tinnitus s cores after 1Hz rTMS over the auditory cortex with benefits remaining up to 6 months after treatment (Kleinjung et al. 200 5).", "Some other studies showed no benefit in tinnitus severity after low frequency rTMS on the TPC. Piccirillo et al conducted two randomized controlled studies, the first protocol consisted of 10 sessions and no significant different was found when copai red to sham (Duddy et al. 2011) . The second protocol prolonged the treatment sessions for 20 and still results weren´t different between active and sham groups (Piccirillo et al. 2013) . A recent multicentric study by Landgrebe et al. revealed no benefit after 1Hz rTMS sessions. This randomized controlled trial evaluated 167 patients.", "The limited results obtained in TPC rTMS studies opened a way to combined stimulation areas, specially a combination of low frequency TPC rTMS and high frequency left dorsolateral prefrontal cortex (DLPFC) or low frequency right DMPFC. Kreuzer et al found that aditional right DLPFC low frequency, associated with TPC rTMS seemed pr omissing but there was no sham group in the study and a low effect size (Kreuzer et al. 2011) . De Ridder et al stimulated only the right DLPFC with 1 Hz and found benefits on tinnitus reduction after 10 sessions. Langguth et al, Lehner et al and", "recently Formanek et al studied different superficial stimulated protocols in TPC and DLPFC and found no reductions in tinnitus measures (Formánek et al. 2018; Langguth et Despite the benefits demonstrated in some studies there was still a need for new protocols to establish a clinical indication for rTM S in the treatment of tinnitus. Tinnitus patients are very heterogeneous and tinnitus pathophysiology is quite complex as it involves many central areas and connections. The existing studies use very different protocols, inclusion criteria, patients charac teristics and outcome measures, making them difficult to be compared.", "Stimulations of deeper brain areas arised as different protocols that could optimize results on tinnitus patients. Studies using stimulation of these deeper brain areas, the medial pref rontal cortices, are more comparable to our study. Vanneste et al. (Vanneste et al. 2011) placed a double cone coil (DCC) over the medial frontal cortex (1.5 cm anterior to one -third of the distance from the nasion inion) and tested different stimulation frequencies to observe the best response on tinnitus perception and distress. The presence of a control procedure (ie, placebo effect) was tested at the frequencies that yielded maximal tinnitus suppression rates. Low frequency fr ontal rTMS with the DCC im proved both tinnitus perception and tinnitus distress tra nsiently, but not the higher frequencies. In contrast to Vanneste´s study, our study found good results, with reduction of tinnitus annoyance and loudness, using high frequency rTMS and a figure of e ight coil. Kreuzer et al (Kreu zer et al. 2015) investigated a combined stimulation protocol in a double blind randomized trial using high frequency (10Hz) rTMS at the anterior cingulate cortex (ACC) with DCC followed by low frequency (1Hz) rTMS at the left TPC using a figure of eight coil. They compaired this group with a second group submitted to 1Hz rTMS at the left dorsolateral prefrontal cortex followed by 1Hz TPC rTMS, there was no placebo group. The study failed to show a better outcome for the deep brain stimulation group. Unlike our results, which demontrated better results when stimulating deep cortical areas when compaires to placebo.", "The results of our study are relevant as they demonstrated the effectiveness of rTMS in the treatment of our tinnitus patients, although some limitations have to be pointed out. The small number of patients enrolled is one limitation, as is the relatively short follow up period of 16 weeks. Considering that one of the inclusion criteria of this", "study was that tinnitus had to be present for less than five years, the results cannot assure that rTMS is effective for patients with more chronic tinnitus.", "We believe rTMS is a promissing treatment modality for tinnitus patients, and future studies could investigate specific protocols for different tin nitus subgroups.", "Conclusion:", "Tinnitus treatment with high frequency (10Hz), bilateral, dorsomedial prefrontal cortex rTMS was effective in reducing tinnitus annoyance measured by the Tinnitus Handicap Inventory and tinnitus loudness when compared to sham stimulation. References:", "Anon (2017). COPYRIGHT PROTECTED DOCUMENT , Available at: www.iso.org. Bakker, N., Shahab, S., Giacobbe, P., et al. (2015). rTMS of the Dorsomedial Prefrontal Cortex for Major Depress ion: Safety, Tolerability, Effectiveness, and Outcome Predictors for 10 Hz Versus Intermittent Theta -burst Stimulation. Brain Stimul. , 8, Berlim, M.T., Van Den Eynde, F., Daskalakis, Z.J. (2013a). High -frequency repetitive transcranial magnetic st imulation accelerates and enhances the clinical response to antidepressants in major depression: A meta -analysis of randomized, double -blind, and sham -controlled trials. J. Clin. Psychiatry .", "Berlim, M.T., Van den Eynde, F., Jeff Daskalakis, Z. (2013b). Cli nically Meaningful Efficacy and Acceptability of Low -Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) for Treating Primary Major Depression: A Meta -Analysis of Randomized, Double -Blind and Sham -Controlled Trials. Neuropsychopharmacology , 38, 5 43–551. Available at: http://www.nature.com/articles/npp2012237 [Accessed October 7, 2018]. Deng, Z. -D., Lisanby, S.H., Peterchev, A. V (2014). Coil Design Considerations for Deep Transcranial Magnetic Stimulation. Clin Neurophysiol , 125, 1202 –1212.", "Downar , J., Daskalakis, Z.J. (2013). New targets for rTMS in depression: A review of convergent evidence. Brain Stimul. , 6, 231 –240.", "Duddy, D., Au, D., Kallogjeri, D., et al. (2011). NIH Public Access. , 8641. Eggermont, J.J., Roberts, L.E. (2012). The Neuroscie nce of Tinnitus: Understanding Abnormal and Normal Auditory Perception. Front. Syst. Neurosci. Folmer, R.L., Theodoroff, S.M., Casiana, L., et al. (2015). Repetitive Transcranial Magnetic Stimulation Treatment for Chronic Tinnitus. JAMA Otolaryngol. Neck Surg.", "Formánek, M., Migaľová, P., Krulová, P., et al. (2018). Combined transcranial magnetic stimulation in the treatment of chronic tinnitus. Ann. Clin. Transl. Neurol. Henry, J.A. (2016). “measurement” of Tinnitus. Otol. Neurotol. Henry, J.A., Meikle, M.B. (20 00). Psychoacoustic measures of tinnitus. J. Am. Acad. Audiol. , 11, 138 –55. Available at:", "http://www.ncbi.nlm.nih.gov/pubmed/10755810.", "Jastreboff, P.J., Hazell, J.W.P. (1993). A neurophysiological approach to tinnitus: Clinical implications. Br. J. Audiol. , 27, 7 –17. Available at: http://www.tandfonline.com/doi/full/10.3109/03005369309077884 [Accessed Kleinjung, T., Eichhammer, P., Langguth, B., et al. (2005). Long -term effects of repetitive transcranial magnetic stimulation (rTMS) in pa tients with chronic tinnitus. Otolaryngol. - Head Neck Surg.", "Kreuzer, P.M., Landgrebe, M., Schecklmann, M., et al. (2011). Can Temporal Repetitive Transcranial Magnetic Stimulation be Enhanced by Targeting Affective Components of Tinnitus with Frontal rTMS ? A Randomized Controlled Pilot Trial. Front. Syst. Neurosci.", "Kreuzer, P.M., Lehner, A., Schlee, W., et al. (2015). Combined rTMS treatment targeting the Anterior Cingulate and the Temporal Cortex for the Treatment of Chronic Tinnitus. Sci. Rep.", "Landgrebe, M., Langguth, B., Rosengarth, K., et al. (2009). Structural brain changes in tinnitus: Grey matter decrease in auditory and non -auditory brain areas. Neuroimage .", "Langguth, B., Kleinjung, T., Marienhagen, J., et al. (2007). Transcranial magnetic stimulatio n for the treatment of tinnitus: Effects on cortical excitability. BMC Neurosci.", "Langguth, B., Landgrebe, M., Frank, E., et al. (2014). Effi cacy of different protocols of transcranial magnetic stimulation for the treatment of tinnitus: Pooled analysis of two randomized controlled studies.", "Lanting, C.P., de Kleine, E., van Dijk, P. (2009). Neural activity underlying tinnitus generation: Results from PET and fMRI. Hear. Res.", "Leaver, A.M., Renier, L., Chevillet, M.A., et al. (2011). Dysregulation of Limbic an d Auditory Networks in Tinnitus. Neuron .", "Leaver, A.M., Seydell -Greenwald, A., Rauschecker, J.P. (2016a). Auditory -limbic interactions in chronic tinnitus: Challenges for neuroimaging research. Hear. Res. Leaver, A.M., Turesky, T.K., Seydell -Greenwald, A., et al. (2016b). Intrinsic network activity in tinnitus investigated using functional MRI. Hum. Brain Mapp. Lehner, A., Schecklmann, M., Greenlee, M.W., et al. (2016). Triple -site rTMS for the treatment of chronic tinnitus: A randomized controlled trial. Sci. Rep. Maudoux, A., Lefebvre, P., Cabay, J.E., et al. (2012). Auditory resting -state network connectivity in tinnitus: A functional MRI study. PLoS One . May, A., Hajak, G., Gänßbauer, S., et al. (2007). Structural brain alterations following 5 days of int ervention: Dynamic aspects of neuroplasticity. Cereb. Cortex . Mennemeier, M., Munn, T., Allensworth, M., et al. (2013). Laterality, frequency and replication of rTMS treatment for chronic tinnitus: Pilot studies and a review of maintenance treatment. Hear. Res.", "Mir-Moghtadaei, A., Giacobbe, P., Daskalakis, Z.J., et al. (2016). Validation of a 25% Nasion –Inion Heuristic for Locating the Dorsomedial Prefrontal Cortex for Repetitive Transcranial Magnetic Stimulation. Brain Stimul. Mirz, F. (2000). Cortical Net works Subserving the Perception of Tinnitus - a PET Study. Acta Otolaryngol.", "Mohan, A., De Ridder, D., Vanneste, S. (2016). Emerging hubs in phantom perception connectomics. NeuroImage Clin.", "Møller, A.R. (2011). The role of neural plasticity in tinnitus. I n Textbook of Tinnitus . Momensohn -Santo, T.M.; Russo, I.C.P. (2013). Prática da Audiologia Clínica 5th ed. I. C. P. Momensohn -Santo, T.M.; Russo, ed., São Paulo: Cortez. Onishi, E.T., Coelho, C.C. de B., Oiticica, J., et al. (2018). Tinnitus and sound intolerance: evidence and experience of a Brazilian group. Braz. J. Otorhinolaryngol.", "Piccirillo, J.F., Kallogjeri, D., Nicklaus, J., et al. (2013). Low -frequency repetitive transcranial magnetic stimulation to the temporoparietal junction for tinnitus: Four - week stimulation trial. JAMA Otolaryngol. - Head Neck Surg. Plewnia, C., Reimold, M., Najib, A., et al. (2007). Moderate therapeutic efficacy of positron emission tomography -navigated repetitive transcranial magnetic stimulation for chronic tinnitus: A rand omised, controlled pilot study. J. Neurol. Neurosurg. Psychiatry .", "Rauschecker, J.P., Leaver, A.M., Mühlau, M. (2010). Tuning Out the Noise: Limbic - Auditory Interactions in Tinnitus. Neuron .", "Rauschecker, J.P., May, E.S., Maudoux, A., et al. (2015). Frontost riatal Gating of Tinnitus and Chronic Pain. Trends Cogn. Sci.", "De Ridder, D., Song, J.J., Vanneste, S. (2013). Frontal cortex TMS for tinnitus. Brain Stimul.", "Rossi, S., De Capua, A., Ulivelli, M., et al. (2007). Effects of repetitive transcranial magnetic s timulation on chronic tinnitus: A randomised, crossover, double blind, placebo controlled study. J. Neurol. Neurosurg. Psychiatry .", "Schlee, W., Weisz, N., Bertrand, O., et al. (2008). Using auditory steady state responses to outline the functional connectiv ity in the tinnitus brain. PLoS One . Seydell -Greenwald, A., Leaver, A.M., Turesky, T.K., et al. (2012). Functional MRI evidence for a role of ventral prefrontal cortex in tinnitus. Brain Res. Smith, J.A., Mennemeier, M., Bartel, T., et al. (2007). Repetiti ve transcranial magnetic stimulation for tinnitus: A pilot study. Laryngoscope .", "Tunkel, D.E., Bauer, C.A., Sun, G.H., et al. (2014). Clinical practice guideline: Tinnitus. Otolaryngol. - Head Neck Surg. (United States) .", "Ueyama, T., Donishi, T., Ukai, S., e t al. (2013). Brain Regions Responsible for Tinnitus Distress and Loudness: A Resting -State fMRI Study. PLoS One , 8.", "Valiente, A.R., Fidalgo, A.R., Berrocal, J.R.G., et al. (2015). Hearing threshold levels for an otologically screened population in Spain. Int. J. Audiol.", "Vanneste, S., Plazier, M., Van De Heyning, P., et al. (2011). Repetitive transcranial magnetic stimulation frequency dependent tinnitus improvement by double cone coil prefrontal stimulation. J. Neurol. Neurosurg. Psychiatry , 82, 1160 –1164.", "4.6) Estudo 6: Artigo submetido para publicação The effects of mirtazapine on tinnitus in patients with panic disorder Patricia Ciminellia,1 – Otolaryngologist – corresponding author patriciaciminelli@gmail.com Sergio Machadob – Neuroscientist – secm80@gma il.com Antonio Egidio Nardia – MD, PhD, Psychiatrist, Full professor of psychiatry – antonioenardi@gmail.com", "a Laboratory of Panic and Respiration (LABPR), Institute of Psychiatry (IPUB), Federal University of Rio de Janeiro (UFRJ), Brazil. Rua Venceslau Brás, 71 Botafogo, Rio de Janeiro – RJ, Brazil 22290 -140 bPhysical Activity Neuroscience, Psysical Activity Sciences Postgraduate Program, Salgado de Oliveira University, Niterói, Brazil. Rua Mal. Deodoro, 217 - Bloco A - Centro, Niterói – RJ, Brazil 24030-060", "Abstract:", "Tinnitus is described as a sound perceived in the ears or head that is not generated by an outside source. Depression and anxiety are very common in tinnitus patients, prevalence can be as high as 80% and antidepressants are commonly pres cribed to minimize these comorbid conditions and reduce tinnitus impact on quality of life . Although tinnitus is a very prevalent symptom and impacts patient ´s quality of life in a significant way, there are still no FDA approved drug s to treat tinnitus. The objective of our study is to describe a successful reduction on tinnitus annoyance in patients with panic disorder (PD) and tinnitus treated with mirtazapine . Fourteen patients were included in our final sample, 7 male and 7 female. All patients were ev aluated at baseline, 1 2 weeks and 3 years after the beginning of mirtazapine. Scales and outcomes used were the Hamilton Depression Rating Scale (HAMD), the Clinical Glo bal Impression Scale (CGI -S), the Visual Analog Scale (VAS) and the number of panic att acks. The total treatment with mirtazapine varied from 27 to 36 months (mean SD 32.2/3.7). A statistically s ignificant decrease in the", "tinnitus after the beginning of the panic disorder. The decrease in all the symptoms were homogeneous and sustained for 3 years, when th e last follow up visit was performed. The role of central pathways involved in chronic tinnitus have been well described. Involvement of not only the auditory central pathways but also the limbic system in the generation and maintenance of tinnitus is und oubtful (10–12,22 –24). Treatment approaches capable of modulating the central nervous system seem to be the most effective for tinnitus patients. But, despite the knowledge we h ave, until now, there is no effective treatment to cure tinnitus (2,20) .", "The literatur e regarding tinnitus is very consistent in demonstrating its strong association with psychiatric disorders, mainly anxiety and depression. Langguth et al described the importance of anxiety and depression as predictors of tinnitus severity, being highly re levant in tinnitus diagnosis and prognosis. Studies describe a possible shared neurobiological pathway influencing the development of both depression and anxiety and tinnitus. Co-morbid mental disorders are likely to be the most important factors affecting the disability and suffering of tinnitus patients. Many tinnitus patients have experienced a certain degree of anxiety and depression prior to the onset of the symptom. However, tinnitus can increase the severity of existing psychological disorders or ten dencies (25). Many studies found a high prevalence of tinnitus patients with associated psychiatric disorders, most frequently anxiety and somatoform disorders and often personality disorder s (4,5,7,8,26) . Zoger et al also found 62% of lifetime depression and 45% of anxiety in tinnitus patients (3).", "Antidepressants are probably the most commonly prescribed medications for tinnitus patients.. These drugs seem to work better in tinnitus patients with associated anxiety and/or depression, in patients with more severe tinnitus and in those patients treated for longer periods of time with adequate doses of medications (18,19) . These results are in accordance with our study, our patients were tr eated for a long period with adequate doses of mirtazapine and improvement in both tinnitus and panic were significant and sustained.", "Some studies have evaluated the effects of antidepressants in treatment of tinnitus. Paroxetine has been tested in patien ts with tinnitus, tinnitus and associated anxiety and tinnitus with depression and anxiety. The latest group showed the best results, changes in tinnitus were strongly correlated with changes in both depression and anxiety. This drug", "seems to be effective in the treatment of distressed tinnitus patients with depression and anxiety, reducing both psychiatric symptoms and tinnitus severity (27) . Another study using paroxetine in no ndepressed tinnitus patients showed no benefits and significant side effects (28) . A study using vestipiant with paroxetine and another group using vestipiant alone for tinnitus showed no efficacy in the reduction of the symptom (29). In a double -blind, placebo -controlled study involving subjects with severe tinnitus and severe depression, nortriptyline significantly reduced depression scores, tinnitus disability scores and tinnitus loudness relative to placebo (30). The results suggest that nortriptyline is effective in reducing tinnitus loudness and severity in seve rely depressed tinnitus patients, but has less benefit in non -depressed subjects.", "A study using sertraline in tinnitus patients with depression and anxiety revealed it to be more effective than placebo in reducing tinnitus severity (p=0,024) and loudness (p=0,014) after a 16 week follow up. There was a significant correlation between tinnitus reduction and improvement in depression and anxiety symptoms. The study concluded that sertraline was more effective than placebo in the treatment of severe refracto ry tinnitus (31).", "Trazodone, an atypical antidepressants, was also investigated in tinnitus patients but no signific ant reduction in tinnitus was obtained when compared to placebo (32). There is only one case report, described in the literature, of tinnitus treatment using a low dose of mirtazapine, with successful reduction of the symptom. We were able to demonstrate with our cases a significant reduction in tinnitus with prolonged mirtazapine treatment (33).", "A Cochrane review accessed the effects of antidepressants on tinnitus and evaluated if the effect was due to direct a ction on tinnitus or if the benefit was secondary due to treatment of concomitant psychiatric disorders. Six trials were included, 610 patients. The overall results were insufficient to say antidepressants improve tinnitus (34). Tinnitus patients are very heterogeneous and tinnitus pathophysiology is multifactorial and complex, involving many different central pathways and neurotransmitters. This is probably the most significant reason for the difficulty to find a definite c ure for tinnitus. We believe antidepressants have their role in our patient´s treatment, as it acts on comorbid psychiatric symptoms and ameliorates tinnitus", "annoyance and impact in daily life. We believe antidepressants have an important role in our patie nt´s treatment, as it acts on comorbid psychiatric symptoms and ameliorates tinnitus annoyance and impact in daily life. There may also be a direct effect of antidepressants on tinnitus central pathophysiological mechanisms. The limitations of our study sh ould be pointed out: the study was not placebo controlled; a larger sample would be desirable, as 14 patients is a limited number; and tinnitus was only measured using the VAS, no other scales or measurements were used to improve tinnitus analysis and the study lacked a control group. Yet, the follow up was long, 3 years, and the identified improvements were relevant and sustained. Finally, as stated before, there is, currently, no FDA approved pharmacological treatment for tinnitus. We believe our results are promising and should encourage further studies. Conclusion:", "Our results demonstrate that patients with panic disorder and tinnitus treated with mirtazapine for more than 2 years obtained a successful, significant and sustained reduction on tinnitus a nnoyance, on the number of panic attacks as well as a significant decrease in the scores of the Hamilton Depression Rating Scale and the Clinical Global impression scale.", "References:", "1. Jastreboff PJ, Hazell JWP. A neurophysiological approach to tinnitus: Clinical implications. Br J Audiol [Internet]. 1993 Jan 12 [cited 2019 Feb 26];27(1):7 –17. Available from:", "2. Onishi ET, Coelho CC de B, Oiticica J, Figueiredo RR, Guimarães R de CC, Sanchez TG, et al. Tinnitus and sound intolerance: evidence and experience of a Brazilian group. Braz J Otorhinolaryngol. 2018; 3. Zöger S, Svedlund J, Holgers K -M. Relationship Between Tinnitus Severity and Psychiat ric Disorders. Psychosomatics. 2006; 4. Pinto PCL, Marcelos CM, Mezzasalma MA, Osterne FJ V, de Melo Tavares de Lima MA, Nardi AE. Tinnitus and its association with psychiatric disorders: systematic review. J Laryngol Otol. 2014; 5. De K, Mathias1 V, M ezzasalma MA, Nardi AE. Artigo original Prevalência de", "transtorno de pânico em pacientes com zumbidos The prevalence of panic disorder in patients with tinnitus. Vol. 38, Rev Psiq Clín. 2011.", "6. Harrop -Griffiths J, Katon W, Dobie R, Sakai C, Russo J. Chr onic tinnitus: Association with psychiatric diagnoses. J Psychosom Res. 1987; 7. Pattyn T, Van Den Eede F, Vanneste S, Cassiers L, Veltman DJ, Van De Heyning P, et al. Tinnitus and anxiety disorders: A review. Vol. 333, Hearing Research. 8. Ziai K, Moshtaghi O, Mahboubi H, Djalilian HR. Tinnitus patients suffering from anxiety and depression: A review. In: International Tinnitus Journal. Associacao Medica de Brasilia; 2017. p. 68 –73.", "9. Salazar JW, Meisel K, Smith ER, Q uiggle A, McCoy DB, Amans MR. Depression in Patients with Tinnitus: A Systematic Review. Vol. 161, Otolaryngology - Head and Neck Surgery (United States). SAGE Publications Inc.; 2019. p. 28 –35. 10. Seydell -Greenwald A, Leaver AM, Turesky TK, Morgan S, K im HJ, Rauschecker JP. Functional MRI evidence for a role of ventral prefrontal cortex in tinnitus. Brain Res. 2012; 11. Leaver AM, Seydell -Greenwald A, Rauschecker JP. Auditory -limbic interactions in chronic tinnitus: Challenges for neuroimaging researc h. Hear Res [Internet]. 12. Rauschecker JP, Leaver AM, Mühlau M. Tuning Out the Noise: Limbic -Auditory Interactions in Tinnitus. Neuron. 2010.", "13. Rauschecker JP, May ES, Mau doux A, Ploner M. Frontostriatal Gating of Tinnitus and Chronic Pain. Trends in Cognitive Sciences. 2015.", "14. Landgrebe M, Langguth B, Rosengarth K, Braun S, Koch A, Kleinjung T, et al. Structural brain changes in tinnitus: Grey matter decrease in audito ry and non - auditory brain areas. Neuroimage [Internet]. 2009;46(1):213 –8. Available from: 15. Maudoux A, Lefebvre P, Cabay JE, Demertzi A, Vanhaudenhuyse A, Laureys S, et al. Auditory resting -state networ k connectivity in tinnitus: A functional MRI study. PLoS One. 2012; 16. Mirz F. Cortical Networks Subserving the Perception of Tinnitus - a PET Study.", "Acta Otolaryngol. 2000; 17. Ueyama T, Donishi T, Ukai S, Ikeda Y, Hotomi M, Yamanaka N, et al. Brain Regions Responsible for Tinnitus Distress and Loudness: A Resting -State fMRI Study. PLoS One. 2013;8(6).", "18. Beebe Palumbo D, Joos K, De Ridder D, Vanneste S. The Management and Outcomes of Pharmacological Treatments for Tinnitus. Curr Neuropharmacol. 19. Robinson SK, Viirre ES, Stein MB. Antidepressant therapy in tinnitus. Hear Res. 20. Tunkel DE, Bauer CA, Sun GH, Rosenfeld RM, Chandrasekhar SS, Cunningham ER, et al. Clinical practice guideline: Tinnitus. Otolaryngolo gy - Head and Neck Surgery (United States). 2014.", "21. Robinson S. Antidepressants for treatment of tinnitus. Vol. 166, Progress in Brain 22. Leaver AM, Renier L, Chevillet MA, Morgan S, Kim HJ, Rauschecker JP. Dysregulation o f Limbic and Auditory Networks in Tinnitus. Neuron. 2011; 23. Seydell -Greenwald A, Raven EP, Leaver AM, Turesky TK, Rauschecker JP. Diffusion imaging of auditory and auditory -limbic connectivity in tinnitus: Preliminary evidence and methodological challe nges. Neural Plast. 2014; 24. Leaver AM, Turesky TK, Seydell -Greenwald A, Morgan S, Kim HJ, Rauschecker JP. Intrinsic network activity in tinnitus investigated using functional MRI. Hum Brain Mapp. 2016; 25. Langguth B, Kleinjung T, Landgrebe M. Severe tinnitus and depressive symptoms: A complex interaction. Otolaryngology - Head and Neck Surgery. 2011. 26. Besteher B, Gaser C, Ivanšić D, Guntinas -Lichius O, Dobel C, Nenadić I. Chronic tinnitus and the limbic system: Reappraising brain structural effects of distress and affective symptoms. NeuroImage Clin. 2019;24:101976.", "27. Oishi N, Kanzaki S, Shinden S, Sa ito H, Inoue Y, Ogawa K. Effects of selective serotonin reuptake inhibitor on treating tinnitus in patients stratified for presence of depression or anxiety. Audiol Neurotol. 2010 Mar;15(3):187 –93. 28. Robinson SK, Viirre ES, Bailey KA, Gerke MA, Harris JP, Stein MB. Randomized", "Placebo -Controlled Trial of a Selective Serotonin Reuptake Inhibitor in the Treatment of Nondepressed Tinnitus Subjects. Psychosom Med [Internet]. 2005 Nov;67(6):981 –8. Available from:", "29. Roberts C, Mcferran J, Baguley LM. A Randomized, Controlled Study Comparing the Effects of Vestipitant or Vestipitant and Paroxetine Combination in Subjects With Tinnitus. Vol. 32, Otol Neurotol. 2011.", "30. Sullivan MD, Sakai CS, Rob ert Dobie MA, Katon WJ. TREATMENT OF DEPRESSED TINNITUS PATIENTS WITH NORTRIPTYLINE. Vol. 98, Ann Otol Rhinol Laryngol. 1989.", "31. Zöger S, Svedlund J, Holgers KM. The effects of sertraline on severe tinnitus suffering - A randomized, double -blind, placeb o-controlled study. J Clin Psychopharmacol. 2006 Feb;26(1):32 –9.", "32. Dib GC, Kasse CA, Alves De Andrade T, Ricardo J, Testa G, Laércio O, et al. Tinnitus Treatment with Trazodone Summary [Internet]. Vol. 73, BRAZILIAN JOURNAL OF OTORHINOLARYNGOLOGY. Avai lable from:", "http://www.rborl.org.br/http://www.rborl.org.br/ 33. tinnitus -treatment -with-mirtazapine -2012.", "34. Baldo P, Cook J, Dooley L, Lazzarini R, Molin P. Antidepressants for tinnitus. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd; 2002.", "5) Considerações Finais:", "Os trabalhos descritos acima reforçam a relação do zumbido , e do incômodo relacionado ao sintoma , com transtornos psiquiátricos . Não há dúvidas de que a ansiedade piora o zumbido e o zumbido provoca ansiedade, ger ando assim um ciclo vicioso que resulta em significativa redução na qualidade de vida dos pacientes. Ainda, as evidencias de que o zumbido é gerado no cérebro, nas áreas auditivas e não auditivas, pri ncipal mente naquelas relacionadas ao sistema límbico, no s fazem acreditar que uma abordagem voltada para a neuromodulação, de forma a mudar a atividade neural anormal nessas áreas acometidas, seja, de fato, bastante promissora . Os resultados dos estudos que envolvem", "estimulação magnética transcraniana no trata mento do zumbido têm dado motivos para otimismo , por ém é necessária a busca por estratégias mais eficazes . Acreditamos que o protocolo descrito em nosso trabalho abre o caminho para novos protocolos de EMTr. Outros modalidades de tratamento para o zumbido que modulem a resposta neural relacionada ao sintoma também são interessantes e merecem futuras investigações."]}